Document:

EX-4.1

 Exhibit 4.1 

AEROHIVE NETWORKS, INC. 

FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

This Fourth Amended and Restated Investors’ Rights Agreement (the “Agreement”) is made as of August 23, 2012,
by and among Aerohive Networks, Inc., a Delaware corporation (the “Company”), and the individuals and entities listed on Exhibit A attached hereto (each, a “Investor,” and collectively, the
“Investors”). 
 RECITALS 

A. The Company and certain of the Investors desire to enter into a Series E Preferred Stock Purchase Agreement, dated as of the
date hereof, as may be amended from time to time (the “Series E Purchase Agreement”), pursuant to which such Investors will purchase shares of the Company’s Series E Preferred Stock (the “Series E
Shares”). 
 B. Pursuant to the Series E Purchase Agreement, it is a condition to the closing
(the “Closing”) of the transactions contemplated by the Series E Purchase Agreement that the parties hereto enter into this Agreement. 

C. The Company and the Investors all desire that the transactions contemplated by the Series E Purchase Agreement be consummated. 

D. The Company and certain of the Investors (the “Existing Investors”) entered into the Third Amended and Restated
Investors’ Rights Agreement, dated March 14, 2011 (the “Prior Agreement”). 
 E. Pursuant to
Section 4.2 of the Prior Agreement, the Prior Agreement may be amended with the written consent of the Company and the Investors (as defined in the Prior Agreement) holding a majority of the outstanding Registrable Securities (as defined in the
Prior Agreement). 
 F. The Investors (as defined in the Prior Agreement) executing this Agreement hold sufficient amounts of Registrable
Securities to amend the Prior Agreement, and the parties hereto wish to terminate the Prior Agreement and further desire that this Agreement supersede and replace the Prior Agreement in its entirety. 

NOW, THEREFORE, in consideration of the foregoing premises and certain other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the parties agree as follows: 
 1. Covenants of the Company and the Investors. 

1.1 Financial Information; Inspection Rights. 

 (a) Financial Information. The Company will mail the following reports (in accordance with
the provisions set forth in Section 4.7 hereof) to each Investor who, together with its affiliates, related individuals or entities, continues to hold at least 600,000 shares of Preferred Stock (as defined below) and/or Conversion Stock (as
defined below) (appropriately adjusted for Recapitalizations (as defined below)). 
 (i) As soon as practicable after the
end of each fiscal year, and in any event within ninety (90) days thereafter, annual consolidated financial statements (including a balance sheet, income statement and cash flow statement) of the Company and its subsidiaries for or as of the
end of such fiscal year, prepared in accordance with International Accounting Standards and audited and certified by an accounting firm that is acceptable to Investors holding a majority of the outstanding shares of Preferred Stock. 

(ii) As soon as practicable, and in any event within forty-five (45) days, after
the end of each quarterly accounting period in each fiscal year of the Company, unaudited quarterly consolidated financial statements (including a balance sheet, income statement and cash flow statement) of the Company. 

(iii) As soon as practicable, and in any event within thirty (30) days, after the end of each month, unaudited monthly
consolidated financial statements (including a balance sheet, income statement and cash flow statement) of the Company. 

(iv) As soon as practicable, and in any event at least thirty (30) days prior to the beginning of each fiscal year, an
annual consolidated budget for such fiscal year. 
 (b) Inspection Rights. The Company will afford to each Investor who, with its
affiliates, related individuals or entities, continues to hold at least 600,000 shares of Preferred Stock and/or Conversion Stock (appropriately adjusted for Recapitalizations), and to such Investor’s accountants, counsel and other
representatives acceptable to the Company, reasonable access during normal business hours to all of the Company’s respective properties, books and records. Each such Investor shall have such other access to management and information as is
necessary for it to comply with applicable laws and regulations and reporting obligations. The Company shall not be required to disclose details of contracts with or work performed for specific customers and other business partners where the Company
has determined in good faith that to do so would violate confidentiality obligations to those parties. Investors may exercise their rights under this Section 1.1(b) only for purposes reasonably related to their interests under this Agreement
and related agreements. 
 (c) For purposes of determining the minimum holdings pursuant to this Section 1.1, any Investor which is a
partnership shall be deemed to hold any shares of Preferred Stock originally purchased by such Investor and subsequently distributed to partners of such Investor, but which have not been resold by such partners. If the partnership is still in
existence, the Company may satisfy any obligation to distribute reports to individual partners of the partnership by delivering a single copy of each report to the partnership as agent for the constituent partners. 

(d) The Investors’ rights under this Section 1.1 may be assigned to (i) a transferee or assignee who after such assignment
holds at least 600,000 shares of Registrable Securities (appropriately adjusted for Recapitalizations), (ii) any partner or retired partner of any such Investor 

  
 2 

 
which is a partnership (or any member or retired member of any such Investor which is a limited liability company), (iii) any entity or fund (United States based or non-United States based) which controls, is controlled by or is under common control with any such Investor, or (iv) any family member or trust for the benefit of any such Investor which is an individual,
provided in each case that: (A) such transfer may otherwise be effected in accordance with applicable securities laws, (B) the Company is given prompt notice of the transfer, and (C) such assignee or transferee agrees to be bound by
the terms of this Agreement. 
 1.2 Directors and Officers Indemnification. 

For so long as a director designated by any of the Investors is a member of the Board of Directors of the Company (the
“Board”), the Certificate (as defined below) and Bylaws of the Company shall provide for the indemnification of directors and officers to the maximum extent permitted by Delaware law. 

1.3 Employee Shares. 

Unless otherwise expressly approved by the Board, including either (i) the affirmative vote or consent of two (2) Preferred
Directors (as defined in the Certificate) or (ii) the affirmative vote or consent of holders of at least a majority of the then outstanding shares of Preferred Stock (voting together as a single class and on an as-converted basis), all future
employees of the Company who shall purchase, or receive options to purchase, shares of Common Stock after the Closing shall be required to execute stock purchase or option agreements providing for: (A) vesting of shares over a four (4)
year period with the first twenty-five percent (25%) of such shares vesting upon such employee’s completion of twelve (12) months of continued employment or services, and one forty-eighth (1/48th) of such shares vesting monthly over the next thirty-six (36) months of continued employment or services thereafter (with
acceleration of vesting in accordance with the terms and conditions of the Company’s 2006 Global Share Plan (the “Plan”) if such stock purchase or option agreement is issued under the Plan); and (B) a 180-day lockup period
in connection with the IPO (as defined below). In addition, the Company shall retain a right of first refusal on transfers until its IPO and the right to repurchase unvested shares at the lower of the original purchase price of such shares (i.e., at
cost) or the fair market value of such shares at the time the Company exercises its right to repurchase. 
 1.4 Founder and Key
Employee Stock. 
 Unless otherwise expressly approved by the Board, including the consent of two (2) Preferred Directors, all
shares held by and options to purchase shares of Common Stock granted to (a) Changming Liu and Gang Zhu (the “Founders”) shall be subject to the same vesting schedule and Company right of first refusal and right to repurchase
as set forth in Section 1.3 above; provided, however, that such shares and options shall be subject to “double trigger vesting acceleration” in the form set forth in the Stock Restriction Agreements as in effect on the date hereof
between the Company and each Founder, and (b) David Flynn (the “Key Employee”) shall be subject to the vesting schedule, Company right of first refusal and right to repurchase and the acceleration provisions as set forth in the
applicable forms of option agreements approved by the Board for such Key Employee on February 15, 2007. 

  
 3 

 1.5 Founders’ Compensation. 

The compensation arrangements and terms of employment of the Founders shall be approved by the Board, such approval to include the consent of
two (2) Preferred Directors. 
 1.6 Confidential Information and Invention Assignment Agreements. 

The Company shall cause each officer, employee and consultant of the Company and each of its direct and indirect subsidiaries to enter into a
form of confidential information and invention assignment agreement acceptable to holders of a majority of the outstanding shares of Preferred Stock. 

1.7 Control of Subsidiaries. 

The Company shall institute and shall keep in place arrangements reasonably satisfactory to at least a majority of the members of the Board,
including two (2) of the Preferred Directors, such that the Company (i) will control the operations of any direct or indirect subsidiary of, or entity controlled by, the Company, and (ii) will be permitted to properly consolidate the
financial results of any direct or indirect subsidiary in the consolidated financial statements for the Company. The composition of the board of directors of each subsidiary of, or entity controlled by, the Company, whether now in existence or
formed in the future, shall be reasonably acceptable to at least a majority of the members of the Board, including two (2) of the Preferred Directors. The Company shall, and shall cause any subsidiaries or entities it controls, to comply with
the Company’s policy on the U.S. Foreign Corrupt Practices Act, as amended. The Company shall take all necessary actions to maintain any direct or indirect subsidiary or entity controlled by the Company, whether now in existence of formed in
the future, as is necessary to conduct the Company’s business as conducted or as proposed to be conducted. The Company shall use commercially reasonable efforts to cause each direct or indirect subsidiary of, or entity controlled by, the
Company whether now in existence or formed in the future, to comply in all material respects with all applicable laws, rules and regulations. 

1.8 Observer Rights. 

(a) For so long as the group of purchasers of shares of Series B Preferred Stock of the Company (the “Series B Shares”)
affiliated with KPCB Holdings, Inc. (the “Kleiner Perkins Investors”) pursuant to the Series B Preferred Stock Purchase Agreement dated July 13, 2007, as amended (the “Series B Purchase Agreement”), hold, in
the aggregate, at least thirty percent (30%) of the aggregate number of Series B Shares (as adjusted for Recapitalizations, as defined in the Certificate) initially issued to the Kleiner Perkins Investors, the Company shall invite a
representative of the Kleiner Perkins Investors to attend all meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that
it provides to its directors; provided however, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if the Company determines, upon consultation with counsel, as
appropriate, that (i) access to such information or attendance at such meeting could adversely affect the attorney-client privilege between the Company and its counsel; (ii) access to such information or

  
 4 

 
attendance at such meeting could result in disclosure of trade secrets to the Kleiner Perkins Investors or their representative; or (iii) access to such information or attendance at such
meeting could result in a material conflict of interest between the Kleiner Perkins Investors or their representative and the Company. The Kleiner Perkins Investors agree, and any representative of the Kleiner Perkins Investors will agree, to hold
in confidence and trust and to act in a fiduciary manner with respect to all information provided to them or learned by them in connection with their rights hereunder, except to the extent otherwise required by law and any other regulatory process
to which the Kleiner Perkins Investors are subject. 
 (b) For so long as the group of purchasers of shares of Series E Preferred Stock of
the Company affiliated with Institutional Venture Partners XIII, L.P. (the “IVP Investors”) pursuant to the Series E Preferred Stock Purchase Agreement, hold, in the aggregate, at least thirty percent (30%) of the aggregate
number of Series E Shares (as adjusted for Recapitalizations, as defined in the Certificate) initially issued to the IVP Investors, the Company shall invite a representative of the IVP Investors to attend all meetings of its Board of Directors
in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its directors; provided however, that the Company reserves the right to withhold
any information and to exclude such representative from any meeting or portion thereof if the Company determines, upon consultation with counsel, as appropriate, that (i) access to such information or attendance at such meeting could adversely
affect the attorney-client privilege between the Company and its counsel; (ii) access to such information or attendance at such meeting could result in disclosure of trade secrets to the IVP Investors or their representative; or
(iii) access to such information or attendance at such meeting could result in a material conflict of interest between the IVP Investors or their representative and the Company. The IVP Investors agree, and any representative of the IVP
Investors will agree, to hold in confidence and trust and to act in a fiduciary manner with respect to all information provided to them or learned by them in connection with their rights hereunder, except to the extent otherwise required by law and
any other regulatory process to which the IVP Investors are subject. 
 1.9 Termination of Covenants. 

The covenants set forth in Sections 1.1 to 1.8 shall terminate and be of no further force or effect immediately prior to the earliest of:
(i) closing of the IPO; (ii) with respect to Section 1.1, the date on which the Company is required to file reports with the Commission (as defined below) pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), whichever event shall first occur; or (iii) the effectiveness of a Liquidation Event (as defined in the Certificate); notwithstanding any other provision herein, the covenant set forth in
Section 1.8(a) shall terminate immediately upon the election to the Board of a nominee designated by KPCB Holdings, Inc. or its affiliate pursuant to the Fifth Amended and Restated Voting Agreement, dated as of the date hereof, among the
Company, the Investors, the Founders and certain other stockholders of the Company named therein. 

  
 5 

 2. Registration Rights. 

2.1 Restrictions on Transferability. 

The Preferred Stock and the Restricted Securities shall not be sold, assigned, transferred or pledged except upon the conditions specified in
this Section 2, which conditions are intended to ensure compliance with the provisions of the Securities Act (as defined below). Each holder of Preferred Stock and Restricted Securities will cause any proposed purchaser, assignee, transferee or
pledgee of any such shares held by such holder to agree in writing to take and hold such securities subject to the provisions and upon the conditions specified in this Section 2. 

2.2 Certain Definitions. 

As used in this Agreement, the following terms shall have the following respective meanings: 

(a) “Certificate” means the Company’s Seventh Amended and Restated Certificate of Incorporation, as amended from time to
time. 
 (b) “Commission” shall mean the United States Securities and Exchange Commission or any other federal agency at
the time administering the Securities Act. 
 (c) “Common Stock” shall mean common stock of the Company. 

(d) “Conversion Stock” means the Common Stock issued or issuable pursuant to conversion of Preferred Stock. 

(e) “Eligible Investors” shall mean Investors who or which, along with the Investors’ affiliates, related individuals or
entities, at the time in question, hold at least 600,000 shares of Preferred Stock and/or Conversion Stock (as adjusted for Recapitalizations). 

(f) “Holder” shall mean (i) any Investor holding Registrable Securities, and (ii) any person holding Registrable
Securities to whom the rights under this Section 2 have been transferred in accordance with Section 2.13 hereof; provided, however, that for purposes of this Agreement, a holder of Preferred Stock shall be deemed to be a Holder of the
Registrable Securities issuable upon conversion of such Preferred Stock, as the case may be, and that Holders of Registrable Securities shall not be required by this Agreement to convert their Preferred Stock into Common Stock in order to exercise
registration rights hereunder, until immediately prior to the closing of the relevant offering to which the registration relates. 
 (g)
“Initiating Holders” shall mean any Holders who in the aggregate hold at least twenty-five percent (25%) of the then outstanding Registrable Securities. 

(h) “IPO” shall mean the Company’s first firm commitment underwritten public offering of any of its securities to the
general public pursuant to (i) a registration statement filed under the Securities Act which has been declared effective by the Commission, or (ii) the securities laws applicable to an offering of securities in another jurisdiction
pursuant to which such securities will be listed on an internationally-recognized securities exchange. 

  
 6 

 (i) “Preferred Stock” shall mean the Company’s Series A Preferred Stock,
the Series B Shares, the Company’s Series C Preferred Stock, the Company’s Series D Preferred Stock and Series E Shares of the Company. 

(j) “Qualified Offering” shall mean the Company’s sale of its Common Stock or other securities pursuant to a
registration statement filed under the Securities Act which has been declared effective by the Commission (or securities laws applicable to an offering of securities in another jurisdiction) that results in gross cash proceeds to the Company of at
least US$30,000,000 (other than a registration statement relating either to the sale of securities to employees of the Company pursuant to its stock option, stock purchase or similar plan or a transaction under Rule 145 promulgated under the
Securities Act (“Rule 145”)). 
 (k) “Recapitalizations” shall mean any stock dividend, stock split,
share combination or consolidation, subdivision, reorganization, recapitalization, reclassification or other similar event in relation to the stock of the Company. 

(l) “Registrable Securities” means the Conversion Stock and any Common Stock of the Company issued or issuable in respect of
such Conversion Stock upon Recapitalizations or any Common Stock otherwise issuable with respect to such Conversion Stock, including all shares of Common Stock of the Company issued or issuable upon conversion of any Preferred Stock issued or
issuable upon exercise of any Preferred Stock Purchase Warrant, as any such warrant may be hereafter amended from time to time, issued in connection with that certain Loan and Security Agreement by and between the Company and TriplePoint Capital LLC
dated March 27, 2008; provided, however, that shares of Common Stock shall only be treated as Registrable Securities if and so long as they have not been (i) sold to or through a broker or dealer or underwriter in a public
distribution or a public securities transaction, or (ii) sold or are available for sale in a single sale in the opinion of counsel for the Company in a transaction exempt from the registration and prospectus delivery requirements of the
Securities Act so that all transfer restrictions and restrictive legends with respect thereto are removed upon the consummation of such sale. 

(m) “Registrable Securities then outstanding” (and similar expressions herein) shall mean the number of shares of Common
Stock that are Registrable Securities that are then (A) issued and outstanding, or (B) issuable pursuant to the conversion of then outstanding Preferred Stock. 

(n) The terms “register,” “registered” and “registration” refer to (i) a registration
effected by preparing and filing a registration statement in compliance with the Securities Act, and the declaration or ordering of the effectiveness of such registration statement, or (ii) in the context of a public offering in a jurisdiction
other than the United States, a registration, qualification or filing under the applicable securities laws of such other jurisdiction. 

(o) “Registration Expenses” shall mean all expenses incurred by the Company in complying with Sections 2.5, 2.6 and 2.7
hereof, including, without limitation, all registration, qualification and filing fees, printing expenses, escrow fees, fees and disbursements of counsel for the Company, blue sky fees and expenses, the expense of any special audits incident to or
required by any such registration and the reasonable fees and disbursements of one counsel for all Holders (not to exceed US$40,000), but excluding Selling Expenses. 

  
 7 

 (p) “Restricted Securities” shall mean the securities of the Company required to
bear the legend set forth in Section 2.3 hereof. 
 (q) “Securities Act” shall mean the United States Securities Act
of 1933, as amended. 
 (r) “Selling Expenses” shall mean all underwriting discounts, selling commissions and share
transfer taxes applicable to the securities registered by the Holders and, except as included in the definition of Registration Expenses above, all fees and disbursements of counsel for any Holder. 

2.3 Restrictive Legend. 

Each certificate representing (i) Preferred Stock, (ii) Registrable Securities, and (iii) any other securities issued in
respect of the Preferred Stock or the Conversion Stock upon any Recapitalization, merger, or similar event, shall (unless otherwise permitted by the provisions of Section 2.4 below) be stamped or otherwise imprinted with legends substantially
in the following form (in addition to any legend required under applicable federal, state, local or non-United States law): 

(a) “THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“ACT”). SUCH SECURITIES MAY NOT BE TRANSFERRED UNLESS (A) A REGISTRATION STATEMENT UNDER THE ACT IS IN EFFECT AS TO SUCH TRANSFER OR (B) PURSUANT TO RULE 144, OR (C) IN THE OPINION OF THE COMPANY, REGISTRATION
UNDER THE ACT IS UNNECESSARY IN ORDER FOR SUCH TRANSFER TO COMPLY WITH THE ACT.” 
 (b) “THE SECURITIES REPRESENTED HEREBY ARE
SUBJECT TO A LOCK-UP PERIOD FOLLOWING THE EFFECTIVE DATE OF A REGISTRATION STATEMENT OF THE COMPANY FILED UNDER THE ACT, AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF THESE
SECURITIES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE COMPANY. SUCH LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SECURITIES.” 

Each Investor and Holder consents to the Company making a notation on its records and giving instructions to any transfer agent of the
Preferred Stock or the Registrable Securities in order to implement the restrictions on transfer established in this Section 2. 

2.4 Notice of Proposed Transfers. 

The holder of each certificate representing Restricted Securities by acceptance thereof agrees to comply in all respects with the provisions
of this Section 2.4. Prior to any proposed sale, assignment, transfer or pledge of any Restricted Securities (other than (i) a transfer not involving a change in beneficial ownership, (ii) in transactions involving the distribution
without consideration 

  
 8 

 
of Restricted Securities by the holder to any of its partners, members, or retired partners or members, or to the estate of any of its partners or members or retired partners or members,
(iii) in transactions in compliance with Rule 144 promulgated under the Securities Act (“Rule 144”), or (iv) transfers to any entity or fund (United States based or
non-United States based) which controls, is controlled by or is under common control with such holder), unless there is in effect a registration statement under the Securities Act covering the proposed
transfer, the holder thereof shall give written notice to the Company of such holder’s intention to effect such transfer, sale, assignment or pledge. Each such notice shall describe the manner and circumstances of the proposed transfer, sale,
assignment or pledge in sufficient detail, and if reasonably requested by the Company, shall be accompanied, at such holder’s expense, by either (i) a written opinion of legal counsel who shall be, and whose legal opinion shall be,
reasonably satisfactory to the Company addressed to the Company, to the effect that the proposed transfer of the Restricted Securities may be effected without registration under the Securities Act, or (ii) a “no action” letter
from the Commission to the effect that the transfer of such securities without registration will not result in a recommendation by the staff of the Commission that action be taken with respect thereto, whereupon the holder of such Restricted
Securities shall be entitled to transfer such Restricted Securities in accordance with the terms of the notice delivered by the holder to the Company. The transferees shall be bound by the obligations of the transferor in this Agreement and other
shareholder agreements, including the Market Standoff (as defined in Section 2.14) below. Each certificate evidencing the Restricted Securities transferred as above provided shall bear, except if such transfer is made pursuant to Rule 144,
the appropriate restrictive legends set forth in Section 2.3 above, except that such certificate shall not bear such restrictive legends if in the opinion of counsel for such holder and the Company such legend is not required in order to
establish compliance with any provision of the Securities Act. 
 2.5 Requested Registration. 

(a) Request for Registration. In case the Company shall receive from Initiating Holders a written request that the Company effect any
registration, qualification or compliance with an anticipated aggregate offering price of at least US$10,000,000.00, the Company will: 

(i) promptly give written notice of the proposed registration, qualification or compliance to all other Holders; and 

(ii) as soon as practicable, use its best efforts to effect such registration, qualification or compliance (including, without limitation,
appropriate qualification under applicable blue sky or other state securities laws and appropriate compliance with applicable regulations issued under the Securities Act and any other governmental requirements or regulations) as may be so requested
and as would permit or facilitate the sale and distribution of all or such portion of such Registrable Securities as are specified in such request, together with all or such portion of the Registrable Securities of any Holder or Holders joining in
such request as are specified in a written request received by the Company within twenty (20) days after receipt of such written notice from the Company; provided, however, that the Company shall not be obligated to take any action to effect
any such registration, qualification or compliance pursuant to this Section 2.5: 

  
 9 

 (1) In any particular jurisdiction in which the Company would be required to execute a general
consent to service of process in effecting such registration, qualification or compliance unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; 

(2) Prior to the earlier of (A) the five (5) year anniversary of the date of this Agreement or (B) six (6) months after
the effective date of the IPO in the jurisdiction in which the Initiating Holders have requested such registration be effected; 
 (3) In
any jurisdiction other than (A) the jurisdiction(s) in which the Company has already effected a registered public offering of its equity securities, or (B) if either (i) the Initiating Holders are precluded from exercising their
rights under this Section 2.5 by reason of Section 2.5(a)(ii)(7), or (ii) the Company has not effected a registered public offering of its equity securities in any jurisdiction, the United States; 

(4) During the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of filing of,
and ending on a date six (6) months immediately following the effective date of, any Company-initiated registration statement subject to Section 2.6 below, provided, that the Company is actively employing in good faith all commercially
reasonable efforts to cause such registration statement to become effective; 
 (5) After the Company has effected two (2) such
registrations pursuant to this Section 2.5(a), and such registrations have been declared or ordered effective; 
 (6) If the
Initiating Holders may dispose of shares of Registrable Securities pursuant to a registration statement on Form S-3 under the Securities Act as in effect on the date hereof or any successor form under the
Securities Act (“Form S-3”) pursuant to a request made under Section 2.7 hereof; or 

(7) In the event the Initiating Holders have requested a registration to be effected in a jurisdiction other than the United States, to the
extent the Board determines in its sole discretion that such registration would impose materially more burdensome or costly obligations on the part of the Company as compared to those to which the Company would be subject if the request was for a
registration to be effected in the United States. 
 (b) Underwriting. In the event that a registration pursuant to Section 2.5
is for a registered public offering involving an underwriting, the Company shall so advise the Holders as part of the notice given pursuant to Section 2.5(a)(i). In such event, the right of any Holder to registration pursuant to this
Section 2.5 shall be conditioned upon such Holder’s participation in the underwriting arrangements required by this Section 2.5, and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent
requested shall be limited to the extent provided herein. 
 The Company shall (together with all Holders proposing to distribute their
securities through such underwriting) enter into an underwriting agreement in customary form with the managing underwriter selected for such underwriting by a majority in interest of the Initiating Holders, but subject to the reasonable approval of
the Company. Notwithstanding any other provision of this Section 2.5, if the managing underwriter advises the Initiating Holders in writing that marketing 

  
 10 

 
factors require a limitation of the number of shares to be underwritten, then the Company shall so advise all holders of Registrable Securities and the number of shares of Registrable Securities
that may be included in the registration and underwriting shall be allocated, among all Holders in proportion, as nearly as practicable, to the respective amounts of Registrable Securities held by such Holders at the time of filing the registration
statement, provided, however, that the number of shares of Registrable Securities to be included in such underwriting and registration shall not be reduced unless all securities that are not Registrable Securities are first entirely excluded from
the underwriting and registration. No Registrable Securities excluded from the underwriting by reason of the underwriter’s marketing limitation shall be included in such registration. To facilitate the allocation of shares in accordance with
the above provisions, the Company or the underwriters may round the number of shares allocated to any Holder to the nearest 100 shares. 

If any Holder of Registrable Securities disapproves of the terms of the underwriting, such Holder shall be excluded therefrom by written
notice to the Holder from the Company. The Registrable Securities and/or other securities so excluded shall also be excluded from registration, and such Registrable Securities shall not be transferred in a public distribution prior to
ninety (90) days after the effective date of such registration, or such other shorter period of time as the underwriters may require. 

(c) Board Approval. Any decision by the Company to effect a registered public offering of the Company’s securities in a
jurisdiction outside of the United States shall be made with the approval of the Board. 
 2.6 Company Registration. 

(a) Notice of Registration. If at any time or from time to time the Company shall determine to register any of its securities, either
for its own account or the account of a security holder or holders, other than (i) a registration relating solely to employee benefit or similar plans, (ii) a registration relating solely to a Rule 145 transaction, (iii) a
registration on any form which does not permit secondary sales or does not include substantially the same information as would be required to be included in a registration statement covering the Registrable Securities, or (iv) a registration in
which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered, the Company will: 

(i) promptly give to each Holder written notice thereof; and 

(ii) use all commercially reasonable efforts to include in such registration (and any related qualification under blue sky
laws or other compliance), and in any underwriting involved therein, all the Registrable Securities specified in a written request or requests, made within twenty (20) days after receipt of such written notice from the Company, by any Holder.

 (b) Underwriting. If the registration of which the Company gives notice is for a registered public offering involving an
underwriting, the Company shall so advise the Holders as a part of the written notice given pursuant to Section 2.6(a)(i). In such event the right of any Holder to registration pursuant to this Section 2.6 shall be conditioned upon such
Holder’s participation in 

  
 11 

 
such underwriting and the inclusion of Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their securities through such underwriting
shall (together with the Company and the other holders distributing their securities through such underwriting) enter into an underwriting agreement in customary form with the managing underwriter selected for such underwriting by the Company.
Notwithstanding any other provision of this Section 2.6, if the managing underwriter determines that marketing factors require a limitation of the number of shares to be underwritten, the managing underwriter may limit on a pro rata basis the
number of Registrable Securities to be included in such registration and underwriting, provided, that there shall first be excluded from such registration all securities that are not Registrable Securities. No such reduction shall reduce the amount
of securities of the selling Holders included in the registration below twenty-five percent (25%) of the total amount of securities included in such registration. Notwithstanding the foregoing, if such offering is a Qualified Offering, any or
all of the Registrable Securities of the Holders may be excluded in accordance with this Section 2.6(b), provided that any and all securities of the Company to be sold by other selling stockholders are also excluded. The Company shall so advise
all Holders and other holders distributing their securities through such underwriting and the number of shares of Registrable Securities that may be included in the registration and underwriting shall be allocated among all the Holders in
proportion, as nearly as practicable, to the respective amounts of Registrable Securities held by such Holder at the time of filing the registration statement. To facilitate the allocation of shares in accordance with the above provisions, the
Company may round the number of shares allocated to any Holder or holder to the nearest 100 shares. For purposes of apportionment hereunder, any selling stockholder that is a Holder of Registrable Securities, together with (i) any partner
or retired partner of such Holder (if a partnership), or any member or retired member of such Holder (if a limited liability company), (ii) any entity or fund (United States based or non-United States
based) which controls, is controlled by or is under common control with such Holder, and (iii) any family member or trust for the benefit of such Holder (if an individual), shall be deemed to be a single “selling Holder,” and any pro
rata reduction with respect to such “selling Holder” shall be based upon the aggregate amount of Registrable Securities owned by all such related entities and individuals. If any Holder or holder disapproves of the terms of any such
underwriting, such Holder shall be excluded therefrom by written notice to the Holder from the Company. Any securities excluded from such underwriting shall be excluded from such registration, and shall not be transferred in a public distribution
prior to ninety (90) days after the effective date of the registration statement relating thereto, or such other shorter period of time as the underwriters may require. 

(c) Right to Terminate Registration. The Company shall have the right to terminate or withdraw any registration initiated by it under
this Section 2.6 prior to the effectiveness of such registration whether or not any Holder has elected to include securities in such registration. Registration Expenses of such withdrawn registration shall be borne by the Company. 

2.7 Registration on Form S-3. 

(a) If any Holder or Holders (“S-3 Initiating Holders”) request that the Company file
a registration statement on Form S-3 (or any successor form to Form S-3) for a public offering of shares of the Registrable Securities for which the reasonably
anticipated aggregate price to the public would exceed US$3,000,000.00 and the Company is a registrant entitled to use Form S-3 to register 

  
 12 

 
the Registrable Securities for such an offering, the Company shall use its best efforts to cause such Registrable Securities to be registered for the offering on such form and to cause such
Registrable Securities to be qualified in such jurisdictions as such Holder or Holders may reasonably request, provided, however, that the Company shall not be required to effect more than two (2) registrations pursuant to this Section 2.7
in any twelve (12) month period. The Company shall inform other Holders of the proposed registration and offer them the opportunity to participate. The substantive provisions of Section 2.5(b) shall be applicable to each registration
initiated under this Section 2.7. 
 (b) Notwithstanding the foregoing, the Company shall not be obligated to take any action pursuant
to this Section 2.7: (i) in any particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting such registration, qualification or compliance unless the Company is already
subject to service in such jurisdiction and except as may be required by the Securities Act; or (ii) during the six (6) month period following the effective date of any registration statement pertaining to any underwritten registration of
securities of the Company in which Holders have piggyback registration rights under Section 2.6 (other than a registration of securities in a Rule 145 transaction or with respect to an employee benefit plan). 

2.8 Expenses of Registration. 

All Registration Expenses shall be borne by the Company, provided, however, that the Company shall not be required to pay for any expenses of
any registration proceeding begun pursuant to Section 2.5 hereof if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered (in which case all participating
Holders shall bear such expenses), unless the Holders of a majority of the Registrable Securities agree to forfeit their right to one demand registration pursuant to Section 2.5 hereof, provided, further, however, that if the requested
registration is withdrawn and at the time of such withdrawal the Holders have learned of a material adverse change in the condition, business or prospects of the Company from that known to the Holders at the time of their request and have withdrawn
the request with reasonable promptness following disclosure by the Company of such material adverse change, then the Holders shall not be required to pay any of such expenses or to forfeit their right to one demand registration and shall retain
their rights pursuant to Section 2.5 hereof. All Selling Expenses incurred in connection with all registrations pursuant to Sections 2.5, 2.6 and 2.7 hereof shall be borne by the Holders of the securities so registered pro rata on the
basis of the number of their shares so registered. 
 2.9 Registration Procedures. 

In the case of each registration, qualification or compliance effected by the Company pursuant to this Section 2, the Company will keep
each Holder advised in writing as to the initiation of each registration, qualification and compliance and as to the completion thereof. At its expense the Company will use its commercially reasonable efforts to: 

(a) prepare and file with the Commission a registration statement with respect to such securities and use its best efforts to cause such
registration statement to become and remain effective for ninety (90) days or until the distribution described in the Registration Statement has been completed, whichever is shorter; 

  
 13 

 (b) prepare and file with the Commission such amendments and supplements to such registration
statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement; 

(c) furnish to the Holders participating in such registration and to the underwriters of the securities being registered such reasonable
number of copies of the registration statement, preliminary prospectus, final prospectus and such other documents as such underwriters may reasonably request in order to facilitate the public offering of such securities; 

(d) use all commercially reasonable efforts to register and qualify the securities covered by such registration statement under such other
securities or blue sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general
consent to service of process in any such states or jurisdictions; 
 (e) in the event of any underwritten public offering pursuant to
Sections 2.5 and 2.7 hereof, enter into and perform its obligation under an underwriting agreement in form reasonably necessary to effect the offer and sale of Common Stock, provided such underwriting agreement contains reasonable and customary
provisions, and provided further, that each Holder participating in such underwriting shall also enter into and perform its obligations under such an agreement; 

(f) notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is
required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a
material fact required to be stated therein or necessary to make the statements therein not misleading or incomplete in light of the circumstances then existing, and following such notification promptly prepare and furnish to such seller a
reasonable number of copies of a supplement to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of such shares, such prospectus shall not include an untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the statements therein not misleading or incomplete in light of the circumstances then existing; 

(g) cause all such Registrable Securities registered pursuant hereunder to be listed on each securities exchange on which similar securities
issued by the Company are then listed; and 
 (h) provide a transfer agent and registrar for all Registrable Securities registered pursuant
to this Agreement and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration. 

2.10 Indemnification. 

(a) The Company will indemnify and hold harmless each Holder, each of its officers, directors, trustees and partners and any underwriter (as
defined in the Securities Act) for such Holder, and each person controlling such Holder or underwriter within the meaning of Section 15 of 

  
 14 

 
the Securities Act (each an “Indemnified Person”), with respect to which registration, qualification or compliance has been effected pursuant to this Section 2, against all
expenses, claims, losses, damages or liabilities (or actions in respect thereof), including any of the foregoing incurred in settlement of any litigation, commenced or threatened, arising out of or based on any untrue statement (or alleged untrue
statement) of a material fact contained in any registration statement, prospectus, offering circular or other document, or any amendment or supplement thereto, incident to any such registration, qualification or compliance, or based on any omission
(or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, or any violation by the Company of the
Securities Act, the Exchange Act or any other federal, state or foreign securities law or any rule or regulation promulgated thereunder applicable to the Company in connection with any such registration, qualification or compliance, and the Company
will reimburse each such Indemnified Person and any other expenses reasonably incurred in connection with investigating, preparing or defending any such claim, loss, damage, liability or action; provided, that the Company will not be liable to any
specific Indemnified Person in any such case to the extent that any such claim, loss, damage, liability or expense arises out of or is based on any untrue statement or omission or alleged untrue statement or omission, made in reliance upon and in
conformity with information furnished to the Company by such Indemnified Person for use therein. The foregoing indemnity agreement of the Company and Holders is subject to the condition that, insofar as they relate to any violation made in a
preliminary prospectus but eliminated or remedied in the amended prospectus on file with the Commission at the time the registration statement in question becomes effective or the amended prospectus is filed with the Commission pursuant to
Rule 424(b) of the Securities Act (the “Final Prospectus”), such indemnity agreement shall not inure to the benefit of any Holder if a copy of the Final Prospectus was timely furnished to the party seeking indemnification
and was not furnished to the person asserting the loss, liability, claim or damage at or prior to the time such action is required by the Securities Act. It is agreed that the indemnity agreement contained in this Section 2.10(a) shall not
apply to amounts paid in settlement of any such loss, claim, damage, liability, or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld). 

(b) Each Holder will, if Registrable Securities held by such Holder are included in the securities as to which such registration,
qualification or compliance is being effected, indemnify the Company, each of its directors and officers, each person who controls the Company within the meaning of Section 15 of the Securities Act, and each other such Holder, each of its
officers, trustees, directors, partners, legal counsel, accountants and any underwriter (as defined in the Securities Act) for such Holder and each person controlling such Holder or underwriter within the meaning of Section 15 of the Securities
Act, against all claims, losses, damages and liabilities (or actions in respect thereof) arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any such registration statement, prospectus,
offering circular or other document, or any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse the Company, such other Holders,
such directors, officers, trustees, persons, partners, underwriters or control persons for any legal or any other expenses reasonably incurred in connection with investigating or defending any such claim, loss, damage, liability or action, in each
case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such registration statement, prospectus, offering circular or other document in reliance upon and in
conformity with written information furnished to the 

  
 15 

 
Company provided for use therein, provided, however, that the indemnity agreement contained in this Section 2.10(b) shall not apply to amounts paid in settlement of any such claim, loss,
damage, liability or action if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld. Notwithstanding the foregoing, the liability of each Holder under this subsection (b) shall be
limited to an amount equal to the proceeds of the shares sold by such Holder in the applicable registration out of which the claims arises, less any applicable underwriting discounts and commissions, except in the case of willful fraud by such
Holder. 
 (c) Each party entitled to indemnification under this Section 2.10 (the “Indemnified Party”) shall give
notice to the party required to provide indemnification (the “Indemnifying Party”) promptly after such Indemnified Party has actual knowledge of any claim as to which indemnity may be sought, and the Indemnifying Party shall have
the option to assume the defense of any such claim or any litigation resulting therefrom, provided, that counsel for the Indemnifying Party, who shall conduct the defense of such claim or litigation, shall be approved by the Indemnified Party (whose
approval shall not unreasonably be withheld), and the Indemnified Party may participate in such defense at such party’s expense, provided, however, that an Indemnified Party (together with all other Indemnified Parties that may be represented
without conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the Indemnifying Party, if representation of such Indemnified Party by the counsel retained by the Indemnifying Party
would, in the reasonable judgment of the Board, be inappropriate due to actual or potential differing interests between such Indemnified Party and any other party represented by such counsel in such proceeding and, provided further, that the failure
of any Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Section 2.10 except to the extent such failure to give such notice is materially prejudicial to an Indemnifying
Party’s ability to defend such action and, provided, further, that the Indemnifying Party shall not assume the defense for matters as to which there is a conflict of interest or separate and different defenses. No claim may be settled without
the consent of the Indemnifying Party (which consent shall not be unreasonably withheld). No Indemnifying Party, in the defense of any such claim or litigation, shall, except with the consent of each Indemnified Party, consent to entry of any
judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect to such claim or litigation. 

(d) If the indemnification provided for in this Section 2.10 is held by a court of competent jurisdiction to be unavailable to an
Indemnified Party with respect to any loss, liability, claim, damage or expense referred to therein, then the Indemnifying Party, in lieu of indemnifying such Indemnified Party hereunder, shall contribute to the amount paid or payable by such
Indemnified Party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party on the one hand and of the Indemnified Party on the other in connection with
the statements or omissions that resulted in such loss, liability, claim, damage or expense as well as any other relevant equitable considerations, provided, that in no event shall any contribution by a Holder under this Subsection 2.10(d) exceed
the net proceeds from the public offering received by such Holder. The relative fault of the Indemnifying Party and of the Indemnified Party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a
material fact or the omission to state a material fact relates to information supplied by the Indemnifying Party or by the Indemnified Party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or
prevent such statement or omission. 

  
 16 

 2.11 Information by Holder. 

It shall be a condition precedent to the obligations of the Company to take any action pursuant to this Section 2 with respect to the
Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding such Holder or Holders, the Registrable Securities held by them and the distribution proposed by such Holder or Holders as the
Company may reasonably request in writing and as shall be required in connection with any registration, qualification or compliance referred to in this Section 2. 

2.12 Rule 144 Reporting. 

With a view to making available the benefits of certain rules and regulations of the Commission which may at any time permit the sale of the
Restricted Securities to the public without registration, after such time as a public market exists for the Common Stock of the Company, the Company agrees to use its commercially reasonable efforts to: 

(a) Make and keep public information available, as those terms are understood and defined in Rule 144 under the Securities Act, at all
times after the effective date that the Company becomes subject to the reporting requirements of the Securities Act or the Exchange Act. 

(b) File with the Commission in a timely manner all reports and other documents required of the Company under the Securities Act and the
Exchange Act (at any time after it has become subject to such reporting requirements); 
 (c) So long as the Investor owns any Restricted
Securities, to furnish to the Investor forthwith upon request a written statement by the Company as to its compliance with the reporting requirements of said Rule 144 (at any time after ninety (90) days after the effective date of the
first registration statement filed by the Company for an offering of its securities to the general public in the United States), and of the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements),
a copy of the most recent annual or quarterly report of the Company, and such other reports and documents of the Company and other information in the possession of or reasonably obtainable by the Company as the Investor may reasonably request in
availing itself of any rule or regulation of the Commission allowing the Investor to sell any such securities without registration. 

2.13 Transfer of Registration Rights. 

The rights to cause the Company to register Registrable Securities under Sections 2.5, 2.6 and 2.7 may be assigned by a Holder to a
transferee or assignee of such securities that (i) after such assignment, holds at least 600,000 shares of Registrable Securities (as appropriately adjusted for Recapitalizations), (ii) is a partner or retired partner of such Holder (if a
partnership), or a member or retired member of such Holder (if a limited liability company), (iii) is an entity or fund (United States based or non-United States based) which controls, is controlled by or
is under common control with such Holder, or (iv) is a family member or trust for the benefit of such Holder (if an individual), provided in each case that: (A) such transfer may otherwise be effected in accordance with applicable
securities laws, (B) the Company is given prompt notice of the transfer, and (C) such assignee or transferee agrees to be bound by the terms of this Agreement. 

  
 17 

 2.14 Standoff Agreement. 

In connection with the IPO, each Investor shall not offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase
any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any Common Stock (or other securities) of the Company or enter into any swap, hedging or other
arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Common Stock (or other securities) of the Company held by such Investor (other than those included in the registration) without the
prior written consent of the Company or such underwriters, as the case may be, during the one hundred eighty (180) day period following the effective date of the IPO (or such other period, not to exceed 18 days after the expiration of the
180-day period) as may be requested by the Company or the managing underwriter to accommodate regulatory restrictions on (i) the publication or other distribution of research reports and (ii) analyst recommendations and opinions,
including, but not limited to, the restrictions contained in NASD Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments thereto) (the “Standoff Period”), provided, that all officers and directors of
the Company and holders of at least one percent (1%) of the Company’s outstanding voting securities enter into similar agreements (the “Market Standoff”). Notwithstanding the foregoing, if the Company or the
underwriter shall release from the terms of the foregoing Market Standoff or such agreements any Common Stock (or other securities) (any such amount released, the “Released Amount”), the Company shall immediately so notify all
other Holders in writing and each such Holder shall automatically be released from the Market Standoff provided for in this Section 2.14 that amount of such Holder’s Common Stock (or other securities) subject thereto equal to such
Holder’s pro rata share of the Released Amount, determined according to the amount of Registrable Securities held by such Holder (the “Market Standoff Release”). The Company shall use commercially reasonable efforts to
require the underwriters to provide for the foregoing Market Standoff provision in any market standoff agreement between the stockholders of the Company and the underwriters. Each Investor agrees to execute and deliver such other agreements as may
be reasonably requested by the Company or the underwriter which are consistent with the foregoing or which are necessary to give further effect thereto. The foregoing provisions of this Section 2.14 shall apply only to the IPO and shall not
apply to the sale of any shares to an underwriter pursuant to an underwriting agreement. The underwriters in connection with the IPO are intended third-party beneficiaries of this Section 2.14 and shall have the right, power and authority to
enforce the provisions hereof as though they were a party hereto. 
 2.15 Delay. 

If the Company shall furnish to such Holders a certificate signed by the Chief Executive Officer of the Company stating that in the good faith
judgment of the Board it would be seriously detrimental to the Company or its stockholders for a registration statement to be filed in the near future, then the Company’s obligation to use its best efforts to register, qualify or comply under
Sections 2.5 or 2.7 shall be deferred for a period not to exceed one hundred twenty (120) days from the date of receipt of the written request from the Initiating Holders or S-3 Initiating Holders
(as the case may be), provided, however, that the Company may not exercise its rights under this Section 2.15 more than once in a twelve-month period. 

  
 18 

 2.16 No Injunction. 

No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any such registration as the result of any
controversy that might arise with respect to the interpretation or implementation of this Section 2. 
 2.17 Limitation on
Subsequent Registration Rights. 
 The Company shall not, without the prior written consent of the Holders holding a majority of the
Registrable Securities then outstanding, enter into any agreement with any holder or prospective holder of any securities of the Company that would allow such holder or prospective holder to have registration rights of such securities that are
senior to the registration rights of the Holders as set forth in this Section 2. 
 2.18 Termination. 

The Company shall have no obligations pursuant to Sections 2.5 through 2.7 with respect to: (i) any request for registration made by
any Holder after the earlier of (A) five (5) years after the closing of the IPO or (B) the effectiveness of a Liquidation Event or (ii) Registrable Securities proposed to be sold by a particular Holder in a registration pursuant
to Section 2.5, 2.6 or 2.7, if, in the opinion of counsel to the Company all Registrable Securities held by such Holder (including aggregations of stock under Rule 144) can be sold in any three-month
period without registration in compliance with Rule 144. 
 3. Right of First Offer. 

3.1 Right of First Offer. 

Subject to the terms and conditions specified in this Section 3.1, the Company hereby grants to each Eligible Investor a right of first
offer to purchase its Pro Rata Share (as hereinafter defined) (in whole or in part) with respect to future sales by the Company of New Securities (as hereinafter defined). The rights provided in this Section 3.1 may not be assigned or
transferred; provided, that an Eligible Investor shall be entitled to apportion the right of first offer hereby granted to it among itself, its partners, its retired partners, its members, its retired members, any entity or fund which controls, is
controlled by or under common control with such Eligible Investor, and any immediate family member or trust of such Eligible Investor, in such proportions as such Eligible Investor shall deem appropriate. 

For purposes of this Section 3.1, an Eligible Investor’s “Pro Rata Share” shall mean that number of New Securities
that equals the total number of such New Securities to be sold by the Company, multiplied by the ratio that (i) the number of shares of Common Stock issuable or issued 

  
 19 

 
upon conversion of the Preferred Stock held by such Eligible Investor immediately prior to the issuance of New Securities bears to (ii) the total number of shares of Common Stock of the
Company outstanding immediately prior to the issuance of New Securities (assuming full conversion and exercise of all convertible or exercisable securities, whether vested or unvested, then outstanding). 

Subject to Section 3.1(d), each time the Company proposes to offer any shares of, or securities convertible into or exercisable for any
shares of, any class of its shares (“New Securities”), the Company shall first make an offering of such New Securities to each Eligible Investor in accordance with the following provisions: 

(a) The Company shall deliver a written notice (“Notice”) pursuant to Section 4.7 hereof to each of the Eligible
Investors stating (i) its bona fide intention to offer such New Securities, (ii) the number of such New Securities to be offered, and (iii) the price and a summary of the terms, if any, upon which it proposes to offer such New
Securities. 
 (b) (i) By written notification received by the Company within fifteen (15) business days after delivery of the
Notice (the “Refusal Period”), each Eligible Investor may elect to purchase or obtain, at the price and on the terms specified in the Notice, up to its Pro Rata Share of such New Securities. 

(ii) In the event that any Eligible Investor elects not to purchase its full Pro Rata Share of the New Securities available to it
pursuant to Section 3.1(b)(i) above within the Refusal Period, then the Company shall promptly give written notice (the “Overallotment Notice”) to each of the Eligible Investors that has elected to purchase its full Pro Rata
Share (the “Fully Participating Eligible Investors”), which notice shall set forth the number of New Securities not purchased by the other Eligible Investors (such shares, the “Overallotment New Securities”), and
shall offer the Fully Participating Eligible Investors the right to purchase its pro rata share of the Overallotment New Securities. By written notification received by the Company within five (5) business days after delivery of the
Overallotment Notice, each Fully Participating Eligible Investor may elect to purchase or obtain at the price and terms specified in the Notice, up to its pro rata share of the Overallotment New Securities. For purposes of this
Section 3(b)(ii), each Fully Participating Eligible Investor’s pro rata share shall be the number of Overallotment New Securities multiplied by a fraction, the numerator of which shall be the number of shares of Common Stock (assuming
conversion of all securities then outstanding that are convertible into Common Stock) owned by such Fully Participating Eligible Investor on the date of the Notice and the denominator of which shall be the total number of shares of Common Stock
(assuming conversion of all securities then outstanding that are convertible into Common Stock) owned by all Fully Participating Eligible Investors on the date of the Notice. 

(c) If all New Securities that the Eligible Investors are entitled to obtain pursuant to subsection 3.1(b) are not elected to be obtained as
provided in subsection 3.1(b) hereof, the Company may, during the ninety (90) day period following the expiration of the period provided in subsection 3.1(b) hereof, offer the remaining unsubscribed portion of such New Securities to any person
or persons at a price not less than, and upon terms no more favorable to the offeree than those specified in the Notice. If the Company does not enter into an agreement for the sale of the New Securities within such period, or if such agreement is
not consummated within sixty (60) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless first reoffered to the Eligible Investors in accordance herewith.

  
 20 

 (d) Notwithstanding the foregoing, New Securities does not include shares of Series E Shares
issued pursuant to the Series E Purchase Agreement or Common Stock, Options (as defined in the Certificate) or Convertible Securities (as defined in the Certificate) issued or issuable (or deemed to be issued or issuable pursuant to
Section 4(d)(iii) of the Certificate): 
 (i) upon conversion of Preferred Stock; 

(ii) upon exercise or conversion of Options or arrangements to purchase Common Stock issued from time to time to employees,
officers, directors or consultants of the Company pursuant to any plan or agreement approved by the Board; 
 (iii) pursuant
to Recapitalizations; 
 (iv) upon exercise or conversion of Options, notes or other Convertible Securities outstanding on
the date of the Closing; 
 (v) in a firm commitment underwritten public offering under the Securities Act, or pursuant to
the securities laws applicable to an offering in another jurisdiction pursuant to which securities will be listed on an internationally-recognized securities exchange; 

(vi) pursuant to any bona fide business acquisition of or by the Company, whether by merger, consolidation, sale of assets,
sale or exchange of stock or otherwise, which transaction is approved by the Board and holders of at least a majority of the Preferred Stock then outstanding (voting together as a single class on an as-converted basis); 

(vii) in connection with licensing or intellectual property transactions not related to the raising of capital by the Company
approved by either (A) the Board including either the affirmative vote or consent of two (2) Preferred Directors (as defined in the Certificate) or (B) the affirmative vote or consent of holders of at least a majority of the then
outstanding shares of Preferred Stock (voting together as a single class and on an as-converted basis); 
 (viii) pursuant
to other transactions expressly excluded from this Section 3.1 by the approval of either (A) the Board including either the affirmative vote or consent of two (2) Preferred Directors or (B) the affirmative vote or consent of
holders of at least a majority of the then outstanding shares of Preferred Stock (voting together as a single class and on an as-converted basis). 

3.2 Termination of Right. 

The right of first offer granted hereunder shall expire immediately prior to the first to occur of the following: (i) the closing of the
IPO, and (ii) the effectiveness of a Liquidation Event. 
 4. Miscellaneous 

4.1 Term and Termination. 

  
 21 

 Section 1 shall terminate in accordance with Section 1.9; the registration rights
granted pursuant to Section 2 shall terminate in accordance with Section 2.18; and Section 3 shall terminate in accordance with Section 3.2. 

4.2 Waivers and Amendments. 

With the written consent of the Company and the Investors holding at least a majority of the Registrable Securities then outstanding, the
obligations of the Company and the rights of the Investors under this Agreement may be amended and any of its terms may be waived (either generally or in a particular instance, either retroactively or prospectively and either for a specified period
of time or indefinitely) and any amendments or waivers so approved shall be binding as to all parties; provided, however, that (i) in no event shall Section 1.8(a) be amended, nor the rights provided thereunder waived, without the written
consent of KPCB Holdings, Inc. and (ii) in no event shall Section 1.8(b) be amended, nor the rights provided thereunder waived, without the written consent of Institutional Venture Partners XIII, L.P. Neither this Agreement nor any
provisions hereof may be changed, waived, discharged or terminated orally, but only by a signed statement in writing. Upon the effectuation of each such waiver, consent, agreement, amendment or modification, the Company shall promptly give written
notice thereof to the record holders of the Preferred Stock, Conversion Stock or Founders’ Stock who have not previously consented thereto in writing. Notwithstanding the foregoing, purchasers of Series E Shares after the date hereof
pursuant to the terms of the Series E Purchase Agreement may become parties to this Agreement by executing a counterpart of this Agreement without any amendment of this Agreement pursuant to this paragraph or any consent or approval of any
other party. 
 4.3 Governing Law. 

This Agreement shall be governed by, and construed and enforced in accordance with, the internal laws of the State of California as such laws
are applied to agreements between California residents entered into and to be performed within California without regard to principles of conflicts of laws. Each of the parties hereto irrevocably (i) agrees that any dispute or controversy
arising out of, relating to, or concerning any interpretation, construction, performance or breach of this Agreement, shall be settled by arbitration to be held in Santa Clara County, California, in accordance with the Commercial Arbitration Rules
and Mediation Procedures (including Procedures for Large, Complex Commercial Disputes) (the “Rules”) then in effect of the American Arbitration Association; (ii) waives, to the fullest extent it may effectively do so, any
objection which it may now or hereafter have to the laying of venue of any such arbitration; and (iii) submits to the exclusive jurisdiction of the American Arbitration Association in the State of California in any such arbitration. The
decision of the arbitrator shall be final, conclusive and binding on the parties to the arbitration. Judgment may be entered on the arbitrator’s decision in any court having jurisdiction. The parties to the arbitration shall each pay an equal
share of the costs and expenses of such arbitration, and each party shall separately pay for its respective counsel fees and expenses, provided, however, that the prevailing party in any such arbitration shall be entitled to recover from the non-prevailing party its reasonable costs and attorney fees. 
 4.4 Other Remedies; Specific
Performance. 

  
 22 

 Except as otherwise provided herein, any and all remedies herein expressly conferred upon a party
will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any one remedy will not preclude the exercise of any other remedy. The parties hereto agree
that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to seek
an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof as permitted by Rule 43 of the Rules, this being in addition to any other remedy to which they are entitled at law or
in equity. 
 4.5 Successors and Assigns. 

Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the parties hereto
and their respective successors, assigns, heirs, executors and administrators. 
 4.6 Entire Agreement. 

This Agreement and the Purchase Agreement constitute the full and entire understanding and agreement between the parties with regard to the
subjects hereof, and any and all other written or oral agreements relating to the subject matter hereof existing between the parties hereto are expressly canceled. 

4.7 Notices, etc. 

All notices and other communications required or permitted hereunder shall be in writing and shall be sent by facsimile or mailed by
electronic, registered or certified mail or by overnight courier or otherwise delivered by hand or by messenger, addressed: (i) if to an Investor, at the Investor’s address, as shown on Exhibit A hereto, or at such other
address as the Investor shall have furnished to the Company in writing, (ii) if to any other holder of any shares subject to this Agreement at such address as such holder shall have furnished the Company in writing, or, until any such holder so
furnishes an address to the Company, then to and at the address of the last holder of such shares who has so furnished an address to the Company, or (iii) if to the Company, at the address of its principal corporate offices (attention: Chief
Executive Officer), facsimile: (408) 492-9918, or at such other address as the Company shall have furnished to the Investors with a copy to John T. Sheridan, Wilson Sonsini Goodrich & Rosati, P.C., 650 Page Mill Road, Palo Alto,
California 94304, facsimile: (650) 493-6811. 
 Where a notice is sent by mail, service of the notice shall be deemed to be effected by
properly addressing, pre-paying and mailing a letter containing the notice, and to have been effected at the expiration of three (3) business days after the letter containing the same is mailed as
aforesaid. 
 Where a notice is sent by overnight courier, service of the notice shall be deemed to be effected by properly addressing, and
sending such notice through an internationally recognized express courier service, delivery fees pre-paid, and to have been effected three (3) business days following the day the same is sent as
aforesaid. Notwithstanding anything to the contrary in this Agreement, notices sent to the Investors (and their permitted assigns) shall only be delivered by internationally recognized express courier service pursuant to this paragraph. 

  
 23 

 Where a notice is delivered by facsimile, electronic mail, by hand or by messenger, service of
the notice shall be deemed to be effected upon delivery. 
 4.8 Severability. 

If any provision of this Agreement shall be determined to be invalid, illegal or unenforceable, the validity, legality and enforceability of
the remaining provisions shall not in any way be affected or impaired thereby. 
 4.9 Information Confidential. 

(a) Each Investor will hold in strict confidence and will not disclose, except for purposes of enforcing their rights under and making
investment decisions relating to this Agreement, any confidential information about the Company (which shall include, but is not limited to, any information provided to Investors pursuant to Section 1.1 hereof) or its business received from the
Company except information (i) which the Company authorizes the Investors to use or disclose, (ii) which is known to the Investors prior to its disclosure by the Company, (iii) which becomes generally known in the industry through no
fault of the Investors, (iv) which was independently developed (as evidenced by written records) without any use of the Company’s confidential information, or (v) which Investors are compelled by law to reveal. Any Investor that is a
partnership shall be allowed to disclose confidential information received from the Company about the Company or its business to any former or current partner, limited partner, general partner or management company of such Investor (or any employee
or representative of any of the foregoing) (each of the foregoing, a “Permitted Disclosee”) or legal counsel, accountants or representatives for such Investor or Permitted Disclosee on a confidential basis to the extent necessary to
meet its obligations to such recipient and provided such recipient complies with the applicable confidentiality provisions to which such recipient is subject. 

(b) Anything in this Agreement to the contrary notwithstanding, no Investor by reason of this Agreement shall have access to any trade secrets
or classified information of the Company. The Company shall not be required to comply with any information rights pursuant to Section 1.1 hereof in respect of any Investor whom the Board of Directors reasonably determines in good faith to be a
competitor or an officer, employee, director or holder of more than ten percent (10%) of a competitor. 
 4.10 Titles and
Subtitles. 
 The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement. All references in this Agreement to sections, paragraphs and exhibits shall, unless otherwise provided, refer to sections and paragraphs hereof and exhibits attached hereto. 

4.11 Counterparts. 

This Agreement may be executed in any number of counterparts, each of which shall be enforceable against the parties actually executing such
counterparts, and all of which together shall constitute one instrument. 

  
 24 

 4.12 Delays or Omissions. 

It is agreed that no delay or omission to exercise any right, power or remedy accruing to the Investor, upon any breach or default of the
Company under this Agreement, shall impair any such right, power or remedy, nor shall it be construed to be a waiver of any such breach or default, or any acquiescence therein, or of any similar breach or default thereafter occurring; nor shall any
waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. It is further agreed that any waiver, permit, consent or approval of any kind or character by the Investor of any breach or
default under this Agreement, or any waiver by the Investor of any provisions or conditions of this Agreement must be in writing and shall be effective only to the extent specifically set forth in writing and that all remedies, either under this
Agreement, or by law or otherwise afforded to the Investor, shall be cumulative and not alternative. 
 4.13 Stock Splits.

 All references to the number of shares in this Agreement shall be appropriately adjusted to reflect any Recapitalizations, which may
be made by the Company after the Closing. 
 4.14 Aggregation of Stock. 

All shares of the Company held or acquired by affiliated entities or persons shall be aggregated together for the purpose of determining the
availability of any rights under this Agreement. 
 4.15 Prior Agreement Superseded. The Company and the Investors who are
parties to the Prior Agreement agree that the Prior Agreement is amended, restated and superseded in its entirety to read as set forth herein. 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 25 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

			
	“THE COMPANY”
	
	AEROHIVE NETWORKS, INC.
		
	By:	 	/s/ David Flynn
		 	 David Flynn
 Chief Executive
Officer

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

			
	“INVESTORS”
	
	Institutional Venture Partners XIII, L.P.
		
	By:	 	Institutional Venture Management XIII LLC
	Its:	 	General Partner
		
	By:	 	/s/ Melanie Chladek
		 	 CFO, Administrative Partner

  

			
	Address:	  	 3000 Sand Hill Road
 Building 2, Suite
250
 Menlo Park, CA 94025

  

			
	 NEW ENTERPRISE ASSOCIATES 13,

LIMITED PARTNERSHIP

		
	By:	 	 NEA Partners 13, Limited Partnership,
 its
general partner

		
	By:	 	NEA 13 GP, LTD, its general partner
		
	By:	 	/s/ Krishna Kolluri
	Name:	 	 Krishna Kolluri

	Title:	 	 General Partner

  

			
	NEA VENTURES 2011, L.P.
		
	By:	 	/s/ Louis S. Citron
	Name:	 	 Louis S. Citron

	Title:	 	 Vice-President

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

			
	“INVESTORS”
	
	NORTHERN LIGHT VENTURE FUND, L.P.
		
	By:	 	 Northern Light Partners, L.P.
 its General
Partner

		
	By:	 	 Northern Light Venture Capital, Ltd.
 its
General Partner

		
	By:	 	/s/ Jeffrey Lee
	Name:	 	 Jeffrey Lee

	Title:	 	 Director

  

			
	NORTHERN LIGHT STRATEGIC FUND, L.P.
		
	By:	 	 Northern Light Partners, L.P.
 its General
Partner

		
	By:	 	 Northern Light Venture Capital, Ltd.
 its
General Partner

		
	By:	 	/s/ Jeffrey Lee
	Name:	 	 Jeffrey Lee

	Title:	 	 Director

  

			
	NORTHERN LIGHT PARTNERS FUND, L.P.
		
	By:	 	 Northern Light Partners, L.P.
 its General
Partner

		
	By:	 	 Northern Light Venture Capital, Ltd.
 its
General Partner

		
	By:	 	/s/ Jeffrey Lee
	Name:	 	 Jeffrey Lee

	Title:	 	 Director

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

					
	“INVESTORS”
	
	LIGHTSPEED VENTURE PARTNERS VII, L.P.
		
	By:	 	 Lightspeed General Partner VII, L.P.,

its general partner

		
	By:	 	 Lightspeed Ultimate General Partner VII, Ltd.,

its general partner

			
		 	By:	 	/s/ Christopher J. Schaepe
		 	Name:	 	 Christopher J. Schaepe

		 		 	 Duly Authorized Signatory

  

			
	WS INVESTMENT COMPANY, LLC (2006A)
		
	By:	 	/s/ John T. Sheridan
	Name:	 	John T. Sheridan
	Title:	 	Partner

  

			
	WS INVESTMENT COMPANY, LLC (2006C)
		
	By:	 	/s/ John T. Sheridan
	Name:	 	John T. Sheridan
	Title:	 	Partner

  

			
	KPCB HOLDINGS, INC.
		
	By:	 	/s/ Susan Biglieri
	Name:	 	Susan Biglieri
	Title:	 	CFO

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

	
	“INVESTORS”
	
	DAVID FLYNN
	
	/s/ David Flynn
	
	CHANGMING LIU
	
	/s/ Changming Liu

  

					
	DAG VENTURES IV-QP, L.P.
		
	By:	 	 DAG Ventures Management IV, LLC
 its
General Partner

			
		 	by:	 	/s/ John Cadeddu
		 		 	John Cadeddu, Managing Director

  

					
	DAG VENTURES IV, L.P.
		
	By:	 	 DAG Ventures Management IV, LLC
 its
General Partner

			
		 	by:	 	/s/ John Cadeddu
		 		 	John Cadeddu, Managing Director

  

					
	DAG VENTURES IV-A, LLC
		
	By:	 	 DAG Ventures Management IV, LLC
 its
Managing Member

			
		 	by:	 	/s/ John Cadeddu
		 		 	John Cadeddu, Managing Director

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

			
	FOUR RIVERS PARTNERS, LP
		
	By:	 	/s/ Farouk Ladha
	Name:	 	Farouk Ladha
	Title:	 	Managing Partner

  

			
	FOUR RIVERS PARTNERS II, LP
		
	By:	 	/s/ Farouk Ladha
	Name:	 	Farouk Ladha
	Title:	 	Managing Partner

  

			
	BIG BASIN PARTNERS LP
		
	By:	 	/s/ Frank J. Marshall
	Name:	 	Frank J. Marshall
	Title:	 	General Partner

 Exhibit A 

Investors 
 Name and Address of Investor

 Institutional Venture Partners XIII, L.P. 
 3000 Sand
Hill Road, Building 2, Suite 250 
 Menlo Park, CA 94025 

Northern Light Venture Fund, L.P. 
 c/o Northern Light Venture
Capital 
 2855 Sand Hill Road 
 Menlo Park, California 94025

 Northern Light Strategic Fund, L.P. 
 c/o Northern Light
Venture Capital 
 2855 Sand Hill Road 
 Menlo Park, California
94025 
 Northern Light Partners Fund, L.P. 
 c/o Northern Light
Venture Capital 
 2855 Sand Hill Road 
 Menlo Park, California
94025 
 Lightspeed Venture Partners VII, L.P. 
 2200 Sand Hill
Road 
 Menlo Park, California 94025 
 WS Investment Company,
LLC (2006A) 
 650 Page Mill Road 
 Palo Alto, California 94304

 WS Investment Company, LLC (2006C) 
 650 Page Mill Road 

Palo Alto, California 94304 
 David Flynn 

Jian Tong 
 Shuhua Ge 

Changming Liu 
 Gang Zhu 

KPCB Holdings, Inc. 
 2750 Sand Hill Road 

Menlo Park, CA 94025 
 Lighthouse Capital Partners V, L.P. 

500 Drake’s Landing Road 
 Greenbrae, CA 94904-3011 

Lighthouse Capital Partners V, L.P. 
 500 Drake’s Landing
Road 
 Greenbrae, CA 94904-3011 
 TriplePoint Capital LLC 

2755 Sand Hill Road, Ste. 150 
 Menlo Park, California 94025 

 DAG Ventures IV-QP, L.P. 

251 Lytton Avenue, Suite 200 
 Palo Alto, CA 94301 

DAG Ventures IV, L.P. 
 251 Lytton Avenue, Suite 200 

Palo Alto, CA 94301 
 DAG Ventures IV-A, LLC 

251 Lytton Avenue, Suite 200 
 Palo Alto, CA 94301 

New Enterprise Associates 13, Limited Partnership 
 c/o New
Enterprise Associates 
 1954 Greenspring Dr., Ste 600 

Timonum, MD 21093 
 NEA Ventures 2011, L.P. 

c/o New Enterprise Associates 
 1954 Greenspring Dr., Ste 600 

Timonum, MD 21093 
 Four Rivers Partners, LP 

c/o Four Rivers Group 
 180 Pacific Ave. 

San Francisco, CA 94111 
 Four Rivers Partners II, LP 

c/o Four Rivers Group 
 180 Pacific Ave. 

San Francisco, CA 94111 
 Big Basin Partners LP 

14510 Big Basin Way 
 Saratoga, CA 95070 

 AEROHIVE NETWORKS, INC. 

AMENDMENT NUMBER ONE TO 

FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

This Amendment Number One to Fourth Amended and Restated Investors’ Rights Agreement (this “Amendment”) is dated as of
June 25, 2013 and amends the Fourth Amended and Restated Investors’ Rights Agreement, dated as of August 23, 2012 (the “Investors’ Rights Agreement”), by and among Aerohive Networks, Inc., a Delaware corporation
(the “Company”), and the individuals and entities listed on Exhibit A attached thereto. All capitalized terms used but not defined in this Amendment shall have the meanings assigned to such terms in the Investors’ Rights
Agreement. 
 RECITALS 

WHEREAS, on August 23, 2012, the Company issued and sold an aggregate of 5,099,035 shares of the Company’s Series E Preferred
Stock (the “Series E Preferred”) at a per share price of US$4.4126, to certain investors (the “Existing Series E Investors”) pursuant to a Series E Preferred Stock Purchase Agreement, dated as of August 23,
2012, between the Company and the Existing Series E Investors; 
 WHEREAS, the Company desires to permit the issuance and sale of
additional shares of Series E Preferred to certain investors (the “2013 Series E Investors”), pursuant to a Series E Preferred Stock Purchase Agreement, dated as of even dated herewith, as may be amended from time to time (the
“2013 Purchase Agreement”); 
 WHEREAS, Section 4.2 of the Investors’ Rights Agreement provides that any
term thereof may be amended by the written consent of (i) the Company and (ii) the Investors holding at least a majority of the Registrable Securities then outstanding (the “Requisite Investors”); and 

WHEREAS, the Company and the Requisite Investors desire to amend the Investors’ Rights Agreement as set forth herein to amend the
definitions of the “Series E Purchase Agreement” and the “Series E Shares” in the Investors’ Rights Agreement. 

NOW THEREFORE, in consideration of the foregoing promises and certain other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and the Requisite Investors hereby agree as follows: 
 AGREEMENT

 1. The following definitions in the Investors’ Rights Agreement are hereby amended and restated in their entirety to read as
follows: 
 “Series E Purchase Agreement” shall mean the Series E Preferred Stock Purchase Agreement, dated as of
August 23, 2012, and the Series E Preferred Stock Purchase Agreement, dated as of June 25, 2013, each as may be amended from time to time.” 

“Series E Shares” shall mean shares of the Company’s Series E Preferred Stock issued pursuant to the Series E Purchase
Agreement.” 
 2. Effectiveness. The provisions of this Amendment shall be effective upon the execution hereof by sufficient
parties to amend the Investors’ Rights Agreement. 

 3. Effect of Amendment. Except as set forth in this Amendment, the provisions of the
Investors’ Rights Agreement shall remain unchanged and shall continue in full force and effect. 
 4. Governing Law. This
Amendment shall be governed by, and construed and enforced in accordance with, the internal laws of the State of California as such laws are applied to agreements between California residents entered into and to be performed within California
without regard to principles of conflicts of laws. 
 5. Counterparts. This Amendment may be executed in two or more counterparts,
each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 [Signature Pages
Follow] 

  
 -2- 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment effective as of the day and
year first above written. 
  

			
	“THE COMPANY”
	
	AEROHIVE NETWORKS, INC.
		
	By:	 	/s/ David Flynn
		 	 David Flynn
 Chief Executive
Officer

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment effective as of the day and
year first above written. 
  

			
	“INVESTORS”
	
	NORTHERN LIGHT VENTURE FUND, L.P.
		
	By:	 	 Northern Light Partners, L.P.
 its General
Partner

		
	By:	 	 Northern Light Venture Capital, Ltd.
 its
General Partner

		
	By:	 	/s/ Jeffrey Lee
	Name:	 	 Jeffrey Lee

	Title:	 	 Director

  

			
	NORTHERN LIGHT STRATEGIC FUND, L.P.
		
	By:	 	 Northern Light Partners, L.P.
 its General
Partner

		
	By:	 	 Northern Light Venture Capital, Ltd.
 its
General Partner

		
	By:	 	/s/ Jeffrey Lee
	Name:	 	 Jeffrey Lee

	Title:	 	 Director

  

			
	NORTHERN LIGHT PARTNERS FUND, L.P.
		
	By:	 	 Northern Light Partners, L.P.
 its General
Partner

		
	By:	 	 Northern Light Venture Capital, Ltd.
 its
General Partner

		
	By:	 	/s/ Jeffrey Lee
	Name:	 	 Jeffrey Lee

	Title:	 	 Director

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment effective as of the day and
year first above written. 
  

					
	“INVESTORS”
	
	LIGHTSPEED VENTURE PARTNERS VII, L.P. 
		
	By:	 	 Lightspeed General Partner VII, L.P.,

its general partner

		
	By:	 	 Lightspeed Ultimate General Partner

VII, Ltd., its general partner

			
		 	By:	 	/s/ Christopher J. Schaepe
		 	Name:	 	 Christopher J. Schaepe

		 	 Duly Authorized Signatory

  

			
	INSTITUTIONAL VENTURE PARTNERS XIII, L.P.
		
	By:	 	Institutional Venture Management XIII LLC
	Its:	 	General Partner
		
	By:	 	/s/ Stephen J. Harrick
		 	 Managing Director

  

			
	Address:	  	 3000 Sand Hill Road
 Building 2, Suite
250
 Menlo Park, CA 94025

  

	
	DAVID FLYNN
	
	/s/ David Flynn

  

	
	CHANGMING LIU
	
	/s/ Changming Liu

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment effective as of the day and
year first above written. 
  

			
	“INVESTORS”
	
	NEW ENTERPRISE ASSOCIATES 13, LIMITED PARTNERSHIP
		
	By:	 	 NEA Partners 13, Limited Partnership,
 its
general partner

		
	By:	 	 NEA 13 GP, LTD, its general partner

		
	By:	 	/s/ Louis S. Citron
	Name:	 	Louis S. Citron
	Title:	 	Chief Legal Officer

  

			
	NEA VENTURES 2011, L.P.
		
	By:	 	/s/ Louis S. Citron
	Name:	 	Louis S. Citron
	Title:	 	Vice-President

  

			
	KPCB HOLDINGS, INC.
		
	By:	 	/s/ Paul M. Vronsky
	Name:	 	Paul M. Vronksy
	Title:	 	General Counsel

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment effective as of the day and
year first above written. 
  

					
	“INVESTORS”
	
	DAG VENTURES IV-QP, L.P.
		
	By:	 	 DAG Ventures Management IV, LLC
 its
General Partner

			
		 	by:	 	/s/ John Cadeddu
		 		 	John Cadeddu, Managing Director

  

					
	DAG VENTURES IV, L.P.
		
	By:	 	 DAG Ventures Management IV, LLC
 its
General Partner

			
		 	by:	 	/s/ John Cadeddu
		 		 	John Cadeddu, Managing Director

  

					
	DAG VENTURES IV-A, LLC
		
	By:	 	 DAG Ventures Management IV, LLC
 its
Managing Member

			
		 	by:	 	/s/ John Cadeddu
		 		 	John Cadeddu, Managing Director

 AEROHIVE NETWORKS, INC. 

AMENDMENT NUMBER TWO TO 

FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

This Amendment Number Two to Fourth Amended and Restated Investors’ Rights Agreement (this “Amendment”) is dated as of
August 23, 2013, and amends the Fourth Amended and Restated Investors’ Rights Agreement, dated as of August 23, 2012, as amended (the “Investors’ Rights Agreement”), by and among Aerohive Networks, Inc., a
Delaware corporation (the “Company”), and the individuals and entities listed on Exhibit A attached thereto. All capitalized terms used but not defined in this Amendment shall have the meanings assigned to such terms in the
Investors’ Rights Agreement. 
 RECITALS 

WHEREAS, the Company and the Investors are parties to the Investors’ Rights Agreement. In connection with the execution and
delivery of a loan facility (the “Loan Facility”) with TriplePoint Capital, LLC (“TriplePoint”), the Company will issue a warrant (the “Warrant”) to TriplePoint to acquire shares of the
Company’s preferred stock (the “Warrant Shares”) pursuant to the terms of the Loan Facility; 
 WHEREAS, as a
condition to entering into the Loan Facility, the Company has agreed to grant TriplePoint certain registration rights with respect to the shares of the Company’s Common Stock issuable upon conversion of the Warrant Shares, and the Investors
desire to amend the Investors’ Rights Agreement accordingly; 
 WHEREAS, Section 4.2 of the Investors’ Rights
Agreement provides that any term thereof may be amended by the written consent of (i) the Company and (ii) the Investors holding at least a majority of the Registrable Securities then outstanding (the “Requisite
Investors”); and 
 WHEREAS, the Company and the Requisite Investors desire to amend the Investors’ Rights Agreement as
set forth herein. 
 NOW THEREFORE, in consideration of the foregoing promises and certain other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the Company and the Requisite Investors hereby agree as follows: 
 AGREEMENT

 1. The definition of “Registrable Securities” in Section 2.2(l) of the Investors’ Rights Agreement is
hereby amended and restated in its entirety as follows: 
 ““Registrable Securities” means (i) the Conversion
Stock and any Common Stock of the Company issued or issuable in respect of such Conversion Stock upon Recapitalizations, (ii) any Common Stock otherwise issuable with respect to such Conversion Stock of the shares referenced in (i) above,
and (iii) for purposes of Section 2 of this Agreement only, shares of Common Stock issued or issuable upon conversion of the shares of preferred stock issued or issuable upon exercise or conversion of the TriplePoint Warrants;
provided, however, that shares of Common Stock described in clauses (i), (ii) or (iii) above shall only be treated as Registrable Securities if and so long as they have not been (A) sold to or through a broker or dealer
or underwriter in a public distribution or a public securities transaction, or (B) sold or are available for sale in a single sale in the opinion of counsel for the Company in a transaction exempt from the registration and prospectus delivery
requirements of the Securities Act so that all transfer restrictions and restrictive legends with respect thereto are removed upon the consummation of such sale.” 

 2. The following new definition is added to Section 2.2 of the Investors’ Rights
Agreement: 
 ““TriplePoint Warrants” means (i) the warrant to purchase shares of the Company’s preferred
stock, as may be hereafter amended or supplemented from time to time, issued in connection with that certain Loan and Security Agreement, by and between the Company and TriplePoint Capital LLC (“TriplePoint”), dated March 27,
2008, as may be amended and (ii) the warrant to purchase shares of the Company’s preferred stock, as may be hereafter amended or supplemented from time to time, issued in connection with that certain plain english growth capital loan and
security agreement, by and between the Company and TriplePoint, dated August 23, 2013, as may be amended.” 
 3. Section 4.2
of the Investors’ Rights Agreement is hereby amended and restated in its entirety as follows: 
 “Section 4.2 Waivers
and Amendments. With the written consent of the Company and the Investors holding at least a majority of the Registrable Securities then outstanding, the obligations of the Company and the rights of the Investors under this Agreement may be
amended and any of its terms may be waived (either generally or in a particular instance, either retroactively or prospectively and either for a specified period of time or indefinitely) and any amendments or waivers so approved shall be binding as
to all parties; provided, however, that (i) in no event shall Section 1.8(a) be amended, nor the rights provided thereunder waived, without the written consent of KPCB Holdings, Inc., (ii) in no event shall
Section 1.8(b) be amended, nor the rights provided thereunder waived, without the written consent of Institutional Venture Partners XIII, L.P. and (iii) if any amendment or waiver of Section 2 of this Agreement operates in a manner
that treats TriplePoint materially different from Investors holding shares of the same series and class of stock as the shares into which the TriplePoint Warrants are convertible, the consent of TriplePoint shall also be required for such amendment
or waiver. Neither this Agreement nor any provisions hereof may be changed, waived, discharged or terminated orally, but only by a signed statement in writing. Upon the effectuation of each such waiver, consent, agreement, amendment or modification,
the Company shall promptly give written notice thereof to the record holders of the Preferred Stock, Conversion Stock or Founders’ Stock who have not previously consented thereto in writing. Notwithstanding the foregoing, purchasers of
Series E Shares after the date hereof pursuant to the terms of the Series E Purchase Agreement may become parties to this Agreement by executing a counterpart of this Agreement without any amendment of this Agreement pursuant to this
paragraph or any consent or approval of any other party.” 
 4. For purposes of the Investors’ Rights Agreement, TriplePoint and
any other holder of the Warrant and the preferred stock issuable upon exercise thereof shall be deemed to be the record holder or holders of the Registrable Securities issuable directly or indirectly upon exercise and conversion thereof. 

5. Effectiveness. The provisions of this Amendment shall be effective upon the execution hereof by sufficient parties to amend the
Investors’ Rights Agreement. 
 6. Effect of Amendment. Except as set forth in this Amendment, the provisions of the
Investors’ Rights Agreement shall remain unchanged and shall continue in full force and effect. 
 7. Governing Law. This
Amendment shall be governed by, and construed and enforced in accordance with, the internal laws of the State of California as such laws are applied to agreements between California residents entered into and to be performed within California
without regard to principles of conflicts of laws. 
 8. Counterparts. This Amendment may be executed in two or more counterparts,
each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 [Signature Pages
Follow] 

  
 -2- 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment effective as of the day and
year first above written. 
  

			
	“THE COMPANY”
	
	AEROHIVE NETWORKS, INC.
		
	By:	 	 /s/ David Flynn

		 	David Flynn
		 	Chief Executive Officer

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment effective as of the day and
year first above written. 
  

			
	“INVESTORS”
	
	NORTHERN LIGHT VENTURE FUND, L.P.
		
	By:	 	Northern Light Partners, L.P.
		 	its General Partner
		
	By:	 	Northern Light Venture Capital, Ltd.
		 	its General Partner
		
	By:	 	 /s/ Jeffrey Lee

	Name:	 	Jeffrey Lee
	Title:	 	Director
	
	NORTHERN LIGHT STRATEGIC FUND, L.P.
		
	By:	 	Northern Light Partners, L.P.
		 	its General Partner
		
	By:	 	Northern Light Venture Capital, Ltd.
		 	its General Partner
		
	By:	 	 /s/ Jeffrey Lee

	Name:	 	Jeffrey Lee
	Title:	 	Director
	
	NORTHERN LIGHT PARTNERS FUND, L.P.
		
	By:	 	Northern Light Partners, L.P.
		 	its General Partner
		
	By:	 	Northern Light Venture Capital, Ltd.
		 	its General Partner
		
	By:	 	 /s/ Jeffrey Lee

	Name:	 	Jeffrey Lee
	Title:	 	Director

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment effective as of the day and
year first above written. 
  

			
	“INVESTORS”
	
	WS INVESTMENT COMPANY, LLC (2006A)
		
	By:	 	 /s/ Mark Baudler

	Name:	 	Mark Baudler
	Title:	 	Partner
	
	WS INVESTMENT COMPANY, LLC (2006C)
		
	By:	 	 /s/ Mark Baudler

	Name:	 	Mark Baudler
	Title:	 	Partner
	
	TRIPLEPOINT CAPITAL, LLC
		
	By:	 	 /s/ Sajal Srivastava

	Name:	 	Sajal Srivastava
	Title:	 	COO
	
	LIGHTSPEED VENTURE PARTNERS VII, L.P.
		
	By:	 	Lightspeed General Partner VII,
		 	L.P., its general partner
		
	By:	 	Lightspeed Ultimate General Partner
		 	VII, Ltd., its general partner

 
					
			
		 	By:	 	 /s/ Christopher J. Schaepe

		 	Name:	 	Christopher J. Schaepe
		 	Duly	 	Authorized Signatory
	
	CHANGMING LIU
	
	 /s/ Changming Liu

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment effective as of the day and
year first above written. 
  

			
	“INVESTORS”
	
	NEW ENTERPRISE ASSOCIATES 13, LIMITED PARTNERSHIP
		
	By:	 	NEA Partners 13, Limited Partnership,
		 	its general partner
		
	By:	 	NEA 13 GP, LTD, its general partner
		
	By:	 	 /s/ Louis S. Citron

	Name:	 	Louis S. Citron
	Title:	 	Chief Legal Officer
	
	NEA VENTURES 2011, L.P.
		
	By:	 	 /s/ Louis S. Citron

	Name:	 	Louis S. Citron
	Title:	 	Vice President
	
	Institutional Venture Partners XIII, L.P.
		
	By:	 	Institutional Venture Management XIII LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Stephen J. Harrick

		 	Managing Director

  

			
	Address:        	 	3000 Sand Hill Road
		 	Building 2, Suite 250
		 	Menlo Park, CA 94025

 
			
	
	KPCB HOLDINGS, INC.
		
	By:	 	 /s/ Paul M. Vronsky

	Name:	 	Paul M. Vronsky
	Title:	 	General Counse

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment effective as of the day and
year first above written. 
  

					
	“INVESTORS”
	
	DAG VENTURES IV-QP, L.P.
		
	By:    	 	DAG Ventures Management IV, LLC
		 	its General Partner
			
		 	by:	 	 /s/ John Cadeddu

		 		 	John Cadeddu, Managing Director
	
	DAG VENTURES IV, L.P.
		
	By:	 	DAG Ventures Management IV, LLC
		 	its General Partner
			
		 	by:	 	 /s/ John Cadeddu

		 		 	John Cadeddu, Managing Director
	
	DAG VENTURES IV-A, LLC
		
	By:	 	DAG Ventures Management IV, LLC
		 	its Managing Member
			
		 	by:	 	 /s/ John Cadeddu

		 		 	John Cadeddu, Managing DirectorEX-4.2

 Exhibit 4.2 

THIS WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER
THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS IN ACCORDANCE WITH APPLICABLE REGISTRATION
REQUIREMENTS OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE, TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY
APPLICABLE STATE SECURITIES LAWS. THIS WARRANT MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, TRANSFER, PLEDGE OR HYPOTHECATION OF ANY INTEREST IN ANY OF THE SECURITIES REPRESENTED HEREBY. 

WARRANT TO PURCHASE SHARES OF PREFERRED STOCK 

of 
 AEROHIVE NETWORKS,
INC. 
 Dated as of [insert date] 

Void after the date specified in Section 8 

No. [    ] 
 THIS
CERTIFIES THAT, [Warrantholder Name], or its registered assigns (the “Holder”), is entitled, subject to the provisions and upon the terms and conditions set forth herein, to purchase from Aerohive Networks, Inc., a Delaware
corporation (the “Company”), Shares (as defined below), in the amounts, at such times and at the price per share set forth in Section 1. The term “Warrant” as used herein shall include this
Warrant and any warrants delivered in substitution or exchange therefor as provided herein. 
 The following is a statement of the rights of
the Holder and the conditions to which this Warrant is subject, and to which Holder, by acceptance of this Warrant, agrees: 
 1. Number
and Price of Shares; Exercise Period. 
 (a) Definition of Shares. “Shares” shall mean the class
and series of preferred stock issued by the Company to investors in a Qualified Financing (as defined below) that occurs before the expiration of this Warrant. A “Qualified Financing” is a transaction or series of
transactions pursuant to which the Company issues and sells shares of its preferred stock, with the principal purpose of raising capital, for aggregate gross proceeds of at least US$ [amount] (including any and all amounts received upon the
conversion or cancellation of indebtedness except for the proceeds received from the conversion of the subordinated convertible promissory notes issued pursuant to the Purchase Agreement). The Company currently expects that the shares sold in the
Qualified Financing shall be its Series [    ] Preferred Stock. 
 (b) Number of Shares. Subject to any
previous exercise of the Warrant, the Holder shall have the right to purchase up to the number of Shares that equals the quotient obtained by dividing (x) by (y) the Exercise Price (as defined below), before (or in connection with) the
expiration of this Warrant as provided in Section 8. 

 (c) Exercise Price. The “Exercise Price” per Share shall be
equal to the price per Share of the Shares issued in a Qualified Financing. 
 (d) Exercise Period. This Warrant shall be
exercisable, in whole or in part, after the closing of the Qualified Financing and before the expiration of this Warrant as set forth in Section 8. 

2. Exercise of the Warrant. 

(a) Exercise. The purchase rights represented by this Warrant may be exercised at the election of the Holder, in whole or in
part, in accordance with Section 1, by: 
 (i) the tender to the Company at its principal office (or such other office or agency as the
Company may designate) of a notice of exercise in the form of Exhibit A (the “Notice of Exercise”), duly completed and executed by or on behalf of the Holder, together with the surrender of this Warrant; and 

(ii) the payment to the Company of an amount equal to (x) the Exercise Price multiplied by (y) the number of Shares being purchased,
by (a) wire transfer or certified, cashier’s or other check acceptable to the Company and payable to the order of the Company; (b) surrender and cancellation of promissory notes or other instruments representing indebtedness of the
Company to the Holder; or (c) a combination of (a) and (b). 
 (b) Net Issue Exercise. In lieu of exercising this
Warrant pursuant to Section 2(a)(ii), if the fair market value of one Share is greater than the Exercise Price (at the date of calculation as set forth below), the Holder may elect to receive a number of Shares equal to the value of this
Warrant (or of any portion of this Warrant being canceled) by surrender of this Warrant at the principal office of the Company (or such other office or agency as the Company may designate) together with a properly completed and executed Notice of
Exercise reflecting such election, in which event the Company shall issue to the Holder that number of Shares computed using the following formula: 
  

									
		 	X	  	=    	 	Y (A – B)	  	
	 	  	 	A	  	

 Where: 
  

							
		 	X	  	=	  	The number of Shares to be issued to the Holder
				
		 	Y	  	=	  	The number of Shares purchasable under this Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being canceled (at the date of such calculation)
				
		 	A	  	=	  	The fair market value of one Share (at the date of such calculation)
				
		 	B	  	=	  	The Exercise Price (as adjusted to the date of such calculation)

  
 - 2 - 

 For purposes of the calculation above, the fair market value of one Share shall be determined by
the Board of Directors of the Company, acting in good faith; provided, however, that: 
 (i) where a public market exists for the
Company’s common stock at the time of such exercise, the fair market value per Share shall be the product of (x) the average of the closing bid prices of the common stock or the closing price quoted on the national securities exchange on
which the common stock is listed as published in the Wall Street Journal, as applicable, for the ten (10) trading day period ending five (5) trading days before the date of determination of fair market value and (y) the number
of shares of common stock into which each Share is convertible at the time of such exercise, as applicable; and 
 (ii) if the Warrant is
exercised in connection with the Company’s initial public offering of common stock, the fair market value per Share shall be the product of (x) the per share offering price to the public of the Company’s initial public offering and
(y) the number of shares of common stock into which each Share is convertible at the time of such exercise, as applicable. 
 (c)
Stock Certificates. The rights under this Warrant shall be deemed to have been exercised and the Shares issuable upon such exercise shall be deemed to have been issued immediately before the close of business on the date this Warrant
is exercised in accordance with its terms, and the person entitled to receive the Shares issuable upon such exercise shall be treated for all purposes as the holder of record of such Shares as of the close of business on such date. As promptly as
reasonably practicable on or after such date, and in any event within thirty (30) days thereafter, the Company shall issue and deliver to the person or persons entitled to receive the same a certificate or certificates for that number of shares
issuable upon such exercise. If the rights under this Warrant are exercised in part and have not expired, the Company shall execute and deliver a new Warrant reflecting the number of Shares that remain subject to this Warrant. 

(d) No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of the rights under this Warrant. In lieu of such fractional share to which the Holder would otherwise be entitled, the Company shall make a cash payment equal to the Exercise Price multiplied by such fraction. 

(e) Conditional Exercise. The Holder may exercise this Warrant conditioned upon (and effective immediately before) consummation
of any transaction that would cause the expiration of this Warrant pursuant to Section 8 by so indicating in the notice of exercise. Notwithstanding the foregoing, this Warrant shall not be exercisable following the closing or consummation of a
Change in Control (as defined in Section 8) that occurs prior to a Qualified Financing. 
 (f) Reservation of Stock. The
Company agrees during the term the rights under this Warrant are exercisable to reserve and keep available from its authorized and unissued shares of preferred stock for the purpose of effecting the exercise of this Warrant such number of shares
(and shares of common stock for issuance on conversion of such shares) as shall from time to time be sufficient to effect the exercise of the rights under this Warrant; and if at any time the number of authorized but unissued shares of preferred
stock (and shares of common stock for issuance on conversion of such shares) shall not be sufficient for purposes of the exercise of this Warrant in accordance with its terms and the conversion of the Shares without limitation of such other remedies
as may be available to the Holder, the Company will use all reasonable efforts to take such corporate action as may be necessary to increase its authorized and unissued shares of its preferred stock (and shares of common stock for issuance on
conversion of such shares) to a number of shares as shall be sufficient for such purposes. The Company represents and warrants that all shares that may be issued upon the exercise of this Warrant will, when issued in accordance with the terms
hereof, be validly issued, fully paid and nonassessable. 
 3. Replacement of the Warrant. Subject to the receipt of evidence
reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and substance to the Company
or, in the case of mutilation, on surrender and cancellation of this Warrant, the Company at the expense of the Holder shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor and amount. 

  
 - 3 - 

 4. Transfer of the Warrant. 

(a) Warrant Register. The Company shall maintain a register (the “Warrant Register”) containing the name
and address of the Holder or Holders. Until this Warrant is transferred on the Warrant Register in accordance herewith, the Company may treat the Holder as shown on the Warrant Register as the absolute owner of this Warrant for all purposes,
notwithstanding any notice to the contrary. Any Holder of this Warrant (or of any portion of this Warrant) may change its address as shown on the Warrant Register by written notice to the Company requesting a change. 

(b) Warrant Agent. The Company may appoint an agent for the purpose of maintaining the Warrant Register referred to in
Section 4(a), issuing the Shares or other securities then issuable upon the exercise of the rights under this Warrant, exchanging this Warrant, replacing this Warrant or conducting related activities. 

(c) Transferability of the Warrant. Subject to the provisions of this Warrant with respect to compliance with the Securities Act
of 1933, as amended (the “Securities Act”) and limitations on assignments and transfers, including without limitation compliance with the restrictions on transfer set forth in Section 5, title to this Warrant may be
transferred by endorsement (by the transferor and the transferee executing the assignment form attached as Exhibit B (the “Assignment Form”)) and delivery in the same manner as a negotiable instrument transferable by
endorsement and delivery. 
 (d) Exchange of the Warrant upon a Transfer. On surrender of this Warrant (and a properly endorsed
Assignment Form) for exchange, subject to the provisions of this Warrant with respect to compliance with the Securities Act and limitations on assignments and transfers, the Company shall issue to or on the order of the Holder a new warrant or
warrants of like tenor, in the name of the Holder or as the Holder (on payment by the Holder of any applicable transfer taxes) may direct, for the number of shares issuable upon exercise hereof, and the Company shall register any such transfer upon
the Warrant Register. This Warrant (and the securities issuable upon exercise of the rights under this Warrant) must be surrendered to the Company or its warrant or transfer agent, as applicable, as a condition precedent to the sale, pledge,
hypothecation or other transfer of any interest in any of the securities represented hereby. 
 (e) Taxes. The Company shall
not be required to pay any tax which may be payable for any transfer involved in the issue and delivery of any certificate in a name other than that of the Holder, and the Company shall not be required to issue or deliver any such certificate unless
and until the person or persons requesting the issue thereof shall have paid to the Company the amount of such tax or shall have established to the satisfaction of the Company that such tax has been paid or is not payable. 

5. Restrictions on Transfer of the Warrant and Shares; Compliance with Securities Laws. By acceptance of this Warrant, the Holder
agrees to comply with the following: 
 (a) Restrictions on Transfers. Subject to Section 5(b), this Warrant may
not be transferred or assigned in whole or in part without the Company’s prior written consent (which shall not be unreasonably withheld), and any attempt by Holder to transfer or assign any rights, duties or obligations that arise under this
Warrant without such permission shall be void. Any transfer of this Warrant or the Shares or the shares of common stock issuable upon conversion of the Shares (the “Securities”) must be in compliance with all applicable
federal and state securities laws. The Holder agrees not to make any sale, assignment, transfer, pledge or other disposition of all or any portion of the Securities, or any beneficial interest therein, unless and until the transferee thereof has
agreed in writing for the benefit of the Company to take and hold such Securities subject to, and to be bound by, the terms and conditions set forth in this Warrant to the same extent as if the transferee were the original Holder hereunder, and 

  
 - 4 - 

 (i) there is then in effect a registration statement under the Securities Act covering such
proposed disposition and such disposition is made in accordance with such registration statement, or 
 (ii) (A) such Holder shall have
given prior written notice to the Company of such Holder’s intention to make such disposition and shall have furnished the Company with a detailed description of the manner and circumstances of the proposed disposition, (B) the transferee
shall have confirmed to the satisfaction of the Company in writing, substantially in the form of Exhibit A-1, that the Securities are being acquired (i) solely for the transferee’s own account and not as a nominee for any other party,
(ii) for investment and (iii) not with a view toward distribution or resale, and shall have confirmed such other matters related thereto as may be reasonably requested by the Company, and (C) if requested by the Company, such Holder
shall have furnished the Company, at the Holder’s expense, with (i) an opinion of counsel, reasonably satisfactory to the Company, that such disposition will not require registration of such Securities under the Securities Act or
(ii) a “no action” letter from the Securities and Exchange Commission to the effect that the transfer of such Securities without registration will not result in a recommendation by the staff of the Securities and Exchange Commission
that action be taken with respect thereto, whereupon such Holder shall be entitled to transfer such Securities in accordance with the terms of the notice delivered by the Holder to the Company. It is agreed that the Company will not require opinions
of counsel for transactions made pursuant to Rule 144 except in unusual circumstances. 
 (b) Permitted Transfers. This Warrant
may be transferred or assigned in whole or in part without the Company’s prior written consent pursuant to (i) a transfer not involving a change in beneficial ownership, or (ii) transactions involving the distribution without
consideration of Securities by any Holder to (x) a parent, subsidiary or other affiliate of a Holder that is a corporation, (y) any of the Holder’s partners, members or other equity owners, or retired partners or members, or to the
estate of any of its partners, members or other equity owners or retired partners or members, or (z) a venture capital fund that is controlled by or under common control with one or more general partners or managing members of, or shares the
same management company with, the Holder; provided, in each case, that the Holder shall give written notice to the Company of the Holder’s intention to effect such disposition and shall have furnished the Company with a detailed
description of the manner and circumstances of the proposed disposition. 
 (c) Investment Representation Statement. Unless the
rights under this Warrant are exercised pursuant to an effective registration statement under the Securities Act that includes the Shares with respect to which the Warrant was exercised, it shall be a condition to any exercise of the rights under
this Warrant that the Holder shall have confirmed to the satisfaction of the Company in writing, substantially in the form of Exhibit A-1, that the Shares so purchased are being acquired solely for the Holder’s own account and not as a
nominee for any other party, for investment and not with a view toward distribution or resale and that the Holder shall have confirmed such other matters related thereto as may be reasonably requested by the Company. 

(d) Securities Law Legend. The Securities shall (unless otherwise permitted by the provisions of this Warrant) be stamped or
imprinted with a legend substantially similar to the following (in addition to any legend required by state securities laws): 

  
 - 5 - 

 THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS IN
ACCORDANCE WITH APPLICABLE REGISTRATION REQUIREMENTS OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION
OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS. THIS CERTIFICATE MUST BE SURRENDERED TO THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, TRANSFER, PLEDGE OR HYPOTHECATION OF ANY INTEREST IN ANY OF THE
SECURITIES REPRESENTED HEREBY. 
 (e) Market Stand-off Legend. The Shares issued upon exercise hereof or conversion thereof
shall also be stamped or imprinted with a legend in substantially the following form: 
 THE SHARES REPRESENTED BY THIS CERTIFICATE ARE
SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE, INCLUDING A LOCK-UP PERIOD IN THE EVENT OF A PUBLIC OFFERING, AS SET FORTH IN THE WARRANT PURSUANT TO WHICH THESE SHARES WERE ISSUED, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF
THE COMPANY. 
 (f) Instructions Regarding Transfer Restrictions. The Holder consents to the Company making a notation on its
records and giving instructions to any transfer agent in order to implement the restrictions on transfer established in this Section 5. 

(g) Removal of Legend. The legend referring to federal and state securities laws identified in Section 5(d) stamped on a
certificate evidencing the Shares (and the common stock issuable upon conversion thereof) and the stock transfer instructions and record notations with respect to such securities shall be removed and the Company shall issue a certificate without
such legend to the holder of such securities if (i) such securities are registered under the Securities Act, or (ii) such holder provides the Company with an opinion of counsel reasonably acceptable to the Company to the effect that a sale
or transfer of such securities may be made without registration or qualification. 
 6. Adjustments. Subject to the expiration of this
Warrant pursuant to Section 8, the number and kind of shares purchasable hereunder and the Exercise Price therefor are subject to adjustment from time to time, as follows: 

(a) Merger or Reorganization. If at any time there shall be any reorganization, recapitalization, merger or consolidation (a
“Reorganization”) involving the Company (other than as otherwise provided for herein or as would cause the expiration of this Warrant under Section 8) in which shares of the Company’s stock are converted into or
exchanged for securities, cash or other property, then, as a part of such Reorganization, lawful provision shall be made so that the Holder shall thereafter be entitled to receive upon exercise of this Warrant, the kind and amount of securities,
cash or other property of the successor corporation resulting from such Reorganization, equivalent in value to that which a holder of the Shares deliverable upon exercise of this Warrant would have been entitled in such Reorganization if the right
to purchase the Shares hereunder had been exercised immediately before such Reorganization. In any such case, appropriate adjustment (as determined in good faith by the Board of Directors of the successor corporation) shall be made in the
application of the provisions of this Warrant with respect to the rights and interests of the Holder after such Reorganization to the end that the provisions of this Warrant shall be applicable after the event, as near as reasonably may be, in
relation to any shares or other securities deliverable after that event upon the exercise of this Warrant. 

  
 - 6 - 

 (b) Reclassification of Shares. If the securities issuable upon exercise of this
Warrant are changed into the same or a different number of securities of any other class or classes by reclassification, capital reorganization, conversion of all outstanding shares of the relevant class or series (other than as would cause the
expiration of this Warrant pursuant to Section 8) or otherwise (other than as otherwise provided for herein) (a “Reclassification”), then, in any such event, in lieu of the number of Shares which the Holder would
otherwise have been entitled to receive, the Holder shall have the right thereafter to exercise this Warrant for a number of shares of such other class or classes of stock that a holder of the number of securities deliverable upon exercise of this
Warrant immediately before that change would have been entitled to receive in such Reclassification, all subject to further adjustment as provided herein with respect to such other shares. 

(c) Subdivisions and Combinations. If the outstanding shares of the securities issuable upon exercise of this Warrant are
subdivided (by stock split, by payment of a stock dividend or otherwise) into a greater number of shares of such securities, the number of Shares issuable upon exercise of the rights under this Warrant immediately before such subdivision shall,
concurrently with the effectiveness of such subdivision, be proportionately increased, and the Exercise Price shall be proportionately decreased, and if the outstanding shares of the securities issuable upon exercise of this Warrant are combined (by
reclassification or otherwise) into a lesser number of shares of such securities, the number of Shares issuable upon exercise of the rights under this Warrant immediately before such combination shall, concurrently with the effectiveness of such
combination, be proportionately decreased, and the Exercise Price shall be proportionately increased. 
 (d) Notice of
Adjustments. Upon any adjustment in accordance with this Section 6, the Company shall give notice thereof to the Holder, which notice shall state the event giving rise to the adjustment, the Exercise Price as adjusted and the number of
securities or other property purchasable upon the exercise of the rights under this Warrant, setting forth in reasonable detail the method of calculation of each. The Company shall, upon the written request of any Holder, furnish or cause to be
furnished to such Holder a certificate setting forth (i) such adjustments, (ii) the Exercise Price at the time in effect and (iii) the number of securities and the amount, if any, of other property that at the time would be received
upon exercise of this Warrant. 
 7. Notification of Certain Events. Before this Warrant expires pursuant to Section 8, if the
Company shall authorize: 
 (a) the issuance of any dividend or other distribution on the capital stock of the Company (other than
(i) dividends or distributions otherwise provided for in Section 6, (ii) repurchases of common stock issued to or held by employees, officers, directors or consultants of the Company or its subsidiaries upon termination of their
employment or services pursuant to agreements providing for the right of said repurchase; (iii) repurchases of common stock issued to or held by employees, officers, directors or consultants of the Company or its subsidiaries pursuant to rights
of first refusal or first offer contained in agreements providing for such rights; or (iv) repurchases of capital stock of the Company in connection with the settlement of disputes with any stockholder), whether in cash, property, stock or
other securities; 
 (b) the voluntary liquidation, dissolution or winding up of the Company; or 

(c) any transaction resulting in the expiration of this Warrant pursuant to Section 8(b) or 8(c); 

then the Company shall send to the Holder of this Warrant at least ten (10) days prior written notice of the date on which a record shall be taken for
any such dividend or distribution specified in clause (a) or the expected effective date of any such other event specified in clause (b) or (c), as applicable. The notice provisions set forth in this section may be shortened or waived
prospectively or retrospectively by the consent of the holders of a majority of the Shares issuable upon exercise of the rights under the Warrants. 

  
 - 7 - 

 8. Expiration of the Warrant. This Warrant shall expire and shall no longer be exercisable
as of the earlier of: 
 (a) [time], Pacific Time, on [date]; 

(b) (i) the acquisition of the Company by another entity by means of any transaction or series of related transactions to which the Company is
a party (including, without limitation, any stock acquisition, reorganization, merger or consolidation, but excluding any sale of stock for capital raising purposes and any transaction effected primarily for purposes of changing the Company’s
jurisdiction of incorporation) other than a transaction or series of related transactions in which the holders of the voting securities of the Company outstanding immediately before such transaction or series of related transactions retain,
immediately after such transaction or series of transactions, as a result of shares in the Company held by such holders before such transaction or series of transactions, at least a majority of the total voting power represented by the outstanding
voting securities of the Company or such other surviving or resulting entity (or if the Company or such other surviving or resulting entity is a wholly-owned subsidiary immediately following such acquisition, its parent), or (ii) a sale, lease
or other disposition of all or substantially all of the assets of the Company and its subsidiaries taken as a whole by means of any transaction or series of related transactions, except where such sale, lease or other disposition is to a
wholly-owned subsidiary of the Company (a “Change in Control”); or 
 (c) [time] if a Qualified Financing has not
been completed by such date. 
 9. No Rights as a Stockholder. Nothing contained herein shall entitle the Holder to any rights as a
stockholder of the Company or to be deemed the holder of any securities that may at any time be issuable on the exercise of the rights hereunder for any purpose nor shall anything contained herein be construed to confer upon the Holder, as such, any
right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action (whether upon any recapitalization, issuance of stock, reclassification of stock,
change of par value or change of stock to no par value, consolidation, merger, conveyance or otherwise) or to receive notice of meetings, or to receive dividends or subscription rights or any other rights of a stockholder of the Company until the
rights under the Warrant shall have been exercised and the Shares purchasable upon exercise of the rights hereunder shall have become deliverable as provided herein. 

10. Market Stand-off. The Holder of this Warrant hereby agrees in connection with the Company’s initial public offering of the
Company’s securities, upon request of the Company or the underwriters managing the initial underwritten public offering of the Company’s securities, not to sell, make any short sale of, loan, grant any option for the purchase of, or
otherwise dispose of any common stock (or other securities) of the Company held by the Holder (other than those included in the registration) without the prior written consent of the Company or such underwriters, as the case may be, for such period
of time (not to exceed 180 days (or such longer period not to exceed 18 days after the expiration of the 180-day period as may be requested by the Company or an underwriter to accommodate regulatory restrictions on (i) the publication or other
distribution of research reports and (ii) analyst recommendations and opinions, including, but not limited to, the restrictions contained in NASD Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments
thereto)) from the effective date of such registration as may be requested by the underwriters, provided that each officer, director and stockholder holding 1% or more of the outstanding securities of the Company shall agree to execute a similar
document. The Holder agrees to execute a market stand-off agreement with the underwriters in the offering in customary form consistent with the provisions of this section. Notwithstanding the foregoing, if the Company or the managing underwriter
shall release any shares from the terms of the foregoing lockup or any similar lockup created in connection with the above-mentioned public offering, the Company shall immediately so notify all other Holders and each such Holder shall automatically
be released from its lockup provided for in this Section 10. 

  
 - 8 - 

 11. Representations and Warranties of the Holder. By acceptance of this Warrant, the
Holder represents and warrants to the Company as follows: 
 (a) No Registration. The Holder understands that the Securities
have not been, and will not be, registered under the Securities Act by reason of a specific exemption from the registration provisions of the Securities Act, the availability of which depends upon, among other things, the bona fide nature of
the investment intent and the accuracy of the Holder’s representations as expressed herein or otherwise made pursuant hereto. 
 (b)
Investment Intent. The Holder is acquiring the Securities for investment for its own account, not as a nominee or agent, and not with a view to, or for resale in connection with, any distribution thereof. The Holder has no present
intention of selling, granting any participation in, or otherwise distributing the Securities, nor does it have any contract, undertaking, agreement or arrangement for the same. 

(c) Investment Experience. The Holder has substantial experience in evaluating and investing in private placement transactions of
securities in companies similar to the Company, and has such knowledge and experience in financial or business matters so that it is capable of evaluating the merits and risks of its investment in the Company and protecting its own interests. 

(d) Speculative Nature of Investment. The Holder understands and acknowledges that the Company has a limited financial and
operating history and that its investment in the Company is highly speculative and involves substantial risks. The Holder can bear the economic risk of its investment and is able, without impairing its financial condition, to hold the Securities for
an indefinite period of time and to suffer a complete loss of its investment. 
 (e) Access to Data. The Holder has had an
opportunity to ask questions of officers of the Company, which questions were answered to its satisfaction. The Holder believes that it has received all the information that it considers necessary or appropriate for deciding whether to acquire the
Securities. The Holder understands that any such discussions, as well as any information issued by the Company, were intended to describe certain aspects of the Company’s business and prospects, but were not necessarily a thorough or exhaustive
description. The Holder acknowledges that any business plans prepared by the Company have been, and continue to be, subject to change and that any projections included in such business plans or otherwise are necessarily speculative in nature, and it
can be expected that some or all of the assumptions underlying the projections will not materialize or will vary significantly from actual results. 

(f) Accredited Investor. The Holder is an “accredited investor” within the meaning of Regulation D,
Rule 501(a), promulgated by the Securities and Exchange Commission and agrees to submit to the Company such further assurances of such status as may be reasonably requested by the Company. 

  
 - 9 - 

 (g) Residency. The residency of the Holder (or, in the case of a partnership or
corporation, such entity’s principal place of business) is correctly set forth on the signature page hereto. 
 (h) Restrictions
on Resales. The Holder acknowledges that the Securities must be held indefinitely unless subsequently registered under the Securities Act or an exemption from such registration is available. The Holder is aware of the provisions of
Rule 144 promulgated under the Securities Act, which permit resale of shares purchased in a private placement subject to the satisfaction of certain conditions, which may include, among other things, the availability of certain current public
information about the Company; the resale occurring not less than a specified period after a party has purchased and paid for the security to be sold; the number of shares being sold during any three-month period not exceeding specified limitations;
the sale being effected through a “broker’s transaction,” a transaction directly with a “market maker” or a “riskless principal transaction” (as those terms are defined in the Securities Act or the Securities
Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder); and the filing of a Form 144 notice, if applicable. The Holder acknowledges and understands that the Company may not be satisfying the current public
information requirement of Rule 144 at the time the Holder wishes to sell the Securities and that, in such event, the Holder may be precluded from selling the Securities under Rule 144 even if the other applicable requirements of
Rule 144 have been satisfied. The Holder acknowledges that, if the applicable requirements of Rule 144 are not met, registration under the Securities Act or an exemption from registration will be required for any disposition of the
Securities. The Holder understands that, although Rule 144 is not exclusive, the Securities and Exchange Commission has expressed its opinion that persons proposing to sell restricted securities received in a private offering other than in a
registered offering or pursuant to Rule 144 will have a substantial burden of proof in establishing that an exemption from registration is available for such offers or sales and that such persons and the brokers who participate in the
transactions do so at their own risk. 
 (i) No Public Market. The Holder understands and acknowledges that no public market
now exists for any of the securities issued by the Company and that the Company has made no assurances that a public market will ever exist for the Company’s securities. 

(j) Brokers and Finders. The Holder has not engaged any brokers, finders or agents in connection with the Securities, and the
Company has not incurred nor will incur, directly or indirectly, as a result of any action taken by the Holder, any liability for brokerage or finders’ fees or agents’ commissions or any similar charges in connection with the Securities.

 (k) Legal Counsel. The Holder has had the opportunity to review this Warrant, the exhibits and schedules attached hereto and
the transactions contemplated by this Warrant with its own legal counsel. The Holder is not relying on any statements or representations of the Company or its agents for legal advice with respect to this investment or the transactions contemplated
by this Warrant. 
 (l) Tax Advisors. The Holder has reviewed with its own tax advisors the U.S. federal, state and local and
non-U.S. tax consequences of this investment and the transactions contemplated by this Warrant. With respect to such matters, the Holder relies solely on any such advisors and not on any statements or representations of the Company or any of its
agents, written or oral. The Holder understands that it (and not the Company) shall be responsible for its own tax liability that may arise as a result of this investment and the transactions contemplated by this Warrant. 

  
 - 10 - 

 12. Miscellaneous. 

(a) Amendments. Except as expressly provided herein, neither this Warrant nor any term hereof may be amended, waived, discharged
or terminated other than by a written instrument referencing this Warrant and signed by the Company and the holders of warrants representing not less than a majority of the Shares issuable upon exercise of any and all outstanding Warrants, which
majority does not need to include the consent of the Holder; provided, however, that no such amendment, waiver, discharge, termination or consent shall adversely affect a Holder in a manner different from the effect of such amendment,
waiver, discharge, termination or consent on one or more other holders of Warrants without the adversely affected Holder’s prior written consent. Any amendment, waiver, discharge or termination effected in accordance with this
Section 12(a) shall be binding upon each holder of the Warrants, each future holder of such Warrants and the Company; provided, however, that no special consideration or inducement may be given to any such holder in connection with such
consent that is not given ratably to all such holders, and that such amendment must apply to all such holders equally and ratably in accordance with the number of Shares issuable upon exercise of the Warrants. The Company shall promptly give notice
to all holders of Warrants of any amendment effected in accordance with this Section 12(a). 
 (b) Waivers. No waiver of
any single breach or default shall be deemed a waiver of any other breach or default theretofore or thereafter occurring. 
 (c)
Notices. All notices and other communications required or permitted hereunder shall be in writing and shall be mailed by registered or certified mail, postage prepaid, sent by facsimile or electronic mail (if to the Holder) or
otherwise delivered by hand, messenger or courier service addressed: 
 (i) if to the Holder, to the Holder at the Holder’s address,
facsimile number or electronic mail address as shown in the Company’s records, as may be updated in accordance with the provisions hereof, or until any such Holder so furnishes an address, facsimile number or electronic mail address to the
Company, then to and at the address, facsimile number or electronic mail address of the last holder of this Warrant for which the Company has contact information in its records; or 

(ii) if to the Company, to the attention of the President or Chief Financial Officer of the Company at the Company’s address as shown on
the signature page hereto, or at such other address as the Company shall have furnished to the Holder, with a copy (which shall not constitute notice to the Company) to [Name], Wilson Sonsini Goodrich & Rosati, P.C., 650 Page Mill Road,
Palo Alto, CA 94304-1050. 
 Each such notice or other communication shall for all purposes of this Warrant be treated as effective or
having been given (i) if delivered by hand, messenger or courier service, when delivered, (ii) if sent by mail, at the earlier of its receipt or 72 hours after the same has been deposited in a regularly maintained receptacle for the
deposit of the United States mail, addressed and mailed as aforesaid, or (iii) if sent by facsimile, upon confirmation of facsimile transfer or, if sent by electronic mail, upon confirmation of delivery when directed to the relevant electronic
mail address. Upon any conflict between the Company’s books and records and this Warrant or any notice delivered hereunder, the Company’s books and records will control absent fraud or error. 

(d) Governing Law. This Warrant and all actions arising out of or in connection with this Warrant shall be governed by and
construed in accordance with the laws of the State of California, without regard to the conflicts of law provisions of the State of California, or of any other state. 

(e) Jurisdiction and Venue. Each of the Holder and the Company irrevocably consents to the exclusive jurisdiction and venue of
any court within Santa Clara County, California, in connection with any matter based upon or arising out of this Warrant or the matters contemplated herein, and agrees that process may be served upon them in any manner authorized by the laws of the
State of California for such persons. 

  
 - 11 - 

 (f) Titles and Subtitles. The titles and subtitles used in this Warrant are used
for convenience only and are not to be considered in construing or interpreting this Warrant. All references in this Warrant to sections, paragraphs and exhibits shall, unless otherwise provided, refer to sections and paragraphs hereof and exhibits
attached hereto. 
 (g) Severability. If any provision of this Warrant becomes or is declared by a court of competent
jurisdiction to be illegal, unenforceable or void, portions of such provision, or such provision in its entirety, if necessary, shall be severed from this Warrant, and such illegal, unenforceable or void provision shall be replaced with a valid and
enforceable provision that will achieve, if possible, the same economic, business and other purposes of the illegal, unenforceable or void provision. The balance of this Warrant shall be enforceable in accordance with its terms. 

(h) Waiver of Jury Trial. EACH OF THE HOLDER AND THE COMPANY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY AND ALL RIGHT
TO TRIAL BY JURY IN ANY LEGAL PROCEEDING (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATED TO THIS WARRANT. If the waiver of jury trial set forth in this paragraph is not enforceable, then any claim or cause of action
arising out of or relating to this Warrant shall be settled by judicial reference pursuant to California Code of Civil Procedure Section 638 et seq. before a referee sitting without a jury, such referee to be mutually acceptable to the
parties or, if no agreement is reached, by a referee appointed by the Presiding Judge of the California Superior Court for Santa Clara County. This paragraph shall not restrict the Holder or the Company from exercising remedies under the Uniform
Commercial Code or from exercising pre-judgment remedies under applicable law. 
 (i) California Corporate Securities Law. THE
SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS WARRANT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION
THEREFOR BEFORE SUCH QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATION BY SECTION 25100, 25102, OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS WARRANT ARE EXPRESSLY
CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT. 
 (j) Saturdays, Sundays and Holidays. If the
last or appointed day for the taking of any action or the expiration of any right required or granted herein shall be a Saturday, Sunday or U.S. federal holiday, then such action may be taken or such right may be exercised on the next succeeding day
that is not a Saturday, Sunday or U.S. federal holiday. 
 (k) Rights and Obligations Survive Exercise of the Warrant. Except
as otherwise provided herein, the rights and obligations of the Company and the Holder under this Warrant shall survive exercise of this Warrant. 

(l) Entire Agreement. Except as expressly set forth herein, this Warrant (including the exhibits attached hereto) constitutes the
entire agreement and understanding of the Company and the Holder with respect to the subject matter hereof and supersede all prior agreements and understandings relating to the subject matter hereof. 

(signature page follows) 

  
 - 12 - 

 The Company and the Holder sign this Warrant as of the date stated on the first page. 

 

			
	AEROHIVE NETWORKS, INC.
		
	By:	 	 
	
	Address:
	
	Fax Number:

 AGREED AND ACKNOWLEDGED, 

[WARRANTHOLDER NAME] 
  

			
	By:	 	 

			
		
	Name:	 	 

			
		
	Title:	 	 

 Address: 
 Fax number: 

Email address: 

 EXHIBIT A 

NOTICE OF EXERCISE 
  

			
	TO:	  	AEROHIVE NETWORKS, INC. (the “Company”)
		
	Attention:	  	President

  

	(1)	Exercise. The undersigned elects to purchase the following pursuant to the terms of the attached warrant: 

  

					
		  	Number of shares: 	  	 

					
			
		  	Type of security: 	  	 

  

	(2)	Method of Exercise. The undersigned elects to exercise the attached warrant pursuant to: 

  

	 	 ̈	A cash payment or cancellation of indebtedness, and tenders herewith payment of the purchase price for such shares in full, together with all applicable transfer taxes, if any. 

 

	 	 ̈	The net issue exercise provisions of Section 2(b) of the attached warrant. 

  

	(3)	Stock Certificate. Please issue a certificate or certificates representing the shares in the name of: 

  

							
		  	 ̈	  	The undersigned	  	
				
		  	 ̈	  	Other—Name:	  	 
				
		  		  	                Address: 	  	 
				
		  		  		  	 

  

	(4)	Unexercised Portion of the Warrant. Please issue a new warrant for the unexercised portion of the attached warrant in the name of: 

 

							
		  	 ̈	  	The undersigned	  	
				
		  	 ̈	  	Other—Name:	  	 
				
		  		  	                Address: 	  	 
				
		  		  		  	 
				
		  	 ̈	  	Not applicable	  	

  

	(5)	Investment Intent. The undersigned represents and warrants that the aforesaid shares are being acquired for investment for its own account, not as a nominee or agent, and not with a view to, or for resale in
connection with, the distribution thereof, and that the undersigned has no present intention of selling, granting any participation in, or otherwise distributing the shares, nor does it have any contract, undertaking, agreement or arrangement for
the same, and all representations and warranties of the undersigned set forth in Section 11 of the attached warrant are true and correct as of the date hereof. 

  
 A-1 

	(6)	Investment Representation Statement and Market Stand-Off Agreement. The undersigned has executed, and delivers herewith, an Investment Representation Statement and Market Stand-Off Agreement in a form
substantially similar to the form attached to the warrant as Exhibit A-1. 

  

	(7)	Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law §232(e), the undersigned consents to the delivery of any notice to stockholders given by the
Company under the Delaware General Corporation Law or the Company’s certificate of incorporation or bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in
the Company’s records), (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records), (iii) posting on an electronic network together
with separate notice to the undersigned of such specific posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned
by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law §232. 

  

	
	  

	(Print name of the warrant holder)
	
	  

	(Signature)
	
	  

	(Name and title of signatory, if applicable)
	
	  

	(Date)
	
	  

	(Fax number)
	
	  

	(Email address)

  
 A-2 

 EXHIBIT A-l 

INVESTMENT REPRESENTATION STATEMENT 

AND 
 MARKET STAND-OFF
AGREEMENT 
  

					
	INVESTOR:	  	  

		
	COMPANY:	  	AEROHIVE NETWORKS, INC.
		
	SECURITIES:	  	THE WARRANT ISSUED ON [DATE] (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES)
			
	DATE:	  	  
	  	

 In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor
represents and warrants to, and agrees with, the Company as follows: 
 1. No Registration. The Investor understands that the
Securities have not been, and will not be, registered under the Securities Act of 1933, as amended (the “Securities Act”), by reason of a specific exemption from the registration provisions of the Securities Act, the
availability of which depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Investor’s representations as expressed herein or otherwise made pursuant hereto. 

2. Investment Intent. The Investor is acquiring the Securities for investment for its own account, not as a nominee or agent, and not
with a view to, or for resale in connection with, any distribution thereof. The Investor has no present intention of selling, granting any participation in, or otherwise distributing the Securities, nor does it have any contract, undertaking,
agreement or arrangement for the same. 
 3. Investment Experience. The Investor has substantial experience in evaluating and
investing in private placement transactions of securities in companies similar to the Company, and has such knowledge and experience in financial or business matters so that it is capable of evaluating the merits and risks of its investment in the
Company and protecting its own interests. 
 4. Speculative Nature of Investment. The Investor understands and acknowledges that the
Company has a limited financial and operating history and that its investment in the Company is highly speculative and involves substantial risks. The Investor can bear the economic risk of its investment and is able, without impairing its financial
condition, to hold the Securities for an indefinite period of time and to suffer a complete loss of its investment. 
 5. Access to
Data. The Investor has had an opportunity to ask questions of officers of the Company, which questions were answered to its satisfaction. The Investor believes that it has received all the information that it considers necessary or appropriate
for deciding whether to acquire the Securities. The Investor understands that any such discussions, as well as any information issued by the Company, were intended to describe certain aspects of the Company’s business and prospects, but were
not necessarily a thorough or exhaustive description. The Investor acknowledges that any business plans prepared by the Company have been, and continue to be, subject to change and that any projections included in such business plans or otherwise
are necessarily speculative in nature, and it can be expected that some or all of the assumptions underlying the projections will not materialize or will vary significantly from actual results. 

  
 A-1-1 

 6. Accredited Investor. The Investor is an “accredited investor” within the
meaning of Regulation D, Rule 501(a), promulgated by the Securities and Exchange Commission and agrees to submit to the Company such further assurances of such status as may be reasonably requested by the Company. 

7. Residency. The residency of the Investor (or, in the case of a partnership or corporation, such entity’s principal place of
business) is correctly set forth on the signature page hereto. 
 8. Restrictions on Resales. The Investor acknowledges that the
Securities must be held indefinitely unless subsequently registered under the Securities Act or an exemption from such registration is available. The Investor is aware of the provisions of Rule 144 promulgated under the Securities Act, which
permit resale of shares purchased in a private placement subject to the satisfaction of certain conditions, which may include, among other things, the availability of certain current public information about the Company; the resale occurring not
less than a specified period after a party has purchased and paid for the security to be sold; the number of shares being sold during any three-month period not exceeding specified limitations; the sale being effected through a “broker’s
transaction,” a transaction directly with a “market maker” or a “riskless principal transaction” (as those terms are defined in the Securities Act or the Securities Exchange Act of 1934, as amended, and the rules and
regulations promulgated thereunder); and the filing of a Form 144 notice, if applicable. The Investor acknowledges and understands that the Company may not be satisfying the current public information requirement of Rule 144 at the time the
Investor wishes to sell the Securities and that, in such event, the Investor may be precluded from selling the Securities under Rule 144 even if the other applicable requirements of Rule 144 have been satisfied. The Investor understands
and acknowledges that, if the applicable requirements of Rule 144 are not met, registration under the Securities Act or an exemption from registration will be required for any disposition of the Securities. The Investor understands that,
although Rule 144 is not exclusive, the Securities and Exchange Commission has expressed its opinion that persons proposing to sell restricted securities received in a private offering other than in a registered offering or pursuant to
Rule 144 will have a substantial burden of proof in establishing that an exemption from registration is available for those offers or sales and that those persons and the brokers who participate in the transactions do so at their own risk. 

9. No Public Market. The Holder understands and acknowledges that no public market now exists for any of the securities issued by the
Company and that the Company has made no assurances that a public market will ever exist for the Company’s securities. 
 10. Brokers
and Finders. The Investor has not engaged any brokers, finders or agents in connection with the Securities, and the Company has not incurred nor will incur, directly or indirectly, as a result of any action taken by the Investor, any liability
for brokerage or finders’ fees or agents’ commissions or any similar charges in connection with the Securities. 
 11. Legal
Counsel. The Investor has had the opportunity to review the Warrant, the exhibits and schedules attached thereto and the transactions contemplated by the Warrant with its own legal counsel. The Investor is not relying on any statements or
representations of the Company or its agents for legal advice with respect to this investment or the transactions contemplated by the Warrant. 

12. Tax Advisors. The Investor has reviewed with its own tax advisors the U.S. federal, state and local and non-U.S. tax consequences of
this investment and the transactions contemplated by the Warrant. With respect to such matters, the Investor relies solely on such advisors and not on any statements or representations of the Company or any of its agents, written or oral. The
Investor understands that it (and not the Company) shall be responsible for its own tax liability that may arise as a result of this investment or the transactions contemplated by the Warrant. 

  
 A-1-2 

 13. Market Stand-off. The Investor agrees in connection with the Company’s initial
public offering of the Company’s securities, upon request of the Company or the underwriters managing the initial underwritten public offering of the Company’s securities, not to sell, make any short sale of, loan, grant any option for the
purchase of, or otherwise dispose of any common stock (or other securities) of the Company held by the Investor (other than those included in the registration) without the prior written consent of the Company or such underwriters, as the case may
be, for such period of time (not to exceed 180 days (or such longer period not to exceed 18 days after the expiration of the 180-day period as may be requested by the Company or an underwriter to accommodate regulatory restrictions on (i) the
publication or other distribution of research reports and (ii) analyst recommendations and opinions, including, but not limited to, the restrictions contained in NASD Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions
or amendments thereto)) from the effective date of such registration as may be requested by the underwriters, provided that each officer, director and stockholder holding 1% or more of the outstanding securities of the Company shall agree to execute
a similar document. The Investor agrees to execute a market stand-off agreement with the underwriters in the offering in customary form consistent with the provisions of this section. Notwithstanding the foregoing, if the Company or the managing
underwriter shall release any shares from the terms of the foregoing lockup or any similar lockup created in connection with the above-mentioned public offering, the Company shall immediately so notify the Investor and such Investor shall
automatically be released from its lockup provided for in this Section 13. 
 (signature page follows) 

  
 A-1-3 

 The Investor is signing this Investment Representation Statement and Market Stand-Off Agreement
on the date first written above. 
  

	
	INVESTOR
	
	
	(Print name of the investor)
	
	
	(Signature)
	
	
	(Name and title of signatory, if applicable)
	
	
	(Street address)
	
	
	(City, state and ZIP)

  
 A-1-4 

 EXHIBIT B 

ASSIGNMENT FORM 
  

					
	ASSIGNOR:	  	  

		
	COMPANY:	  	AEROHIVE NETWORKS, INC.
		
	WARRANT:	  	THE WARRANT TO PURCHASE SHARES OF PREFERRED STOCK ISSUED ON [DATE] (THE “WARRANT”)
			
	DATE:	  	  
	  	

  

	(1)	Assignment. The undersigned registered holder of the Warrant (“Assignor”) assigns and transfers to the assignee named below (“Assignee”) all of the rights of
Assignor under the Warrant, with respect to the number of shares set forth below: 

  

					
		  	Name of Assignee:	  	 
			
		  	Address of Assignee:	  	 
			
		  		  	 
			
		  	Number of Shares Assigned:	  	 

 and does irrevocably constitute and appoint
                     as attorney to make such transfer on the books of AEROHIVE NETWORKS, INC., maintained for the purpose, with full power of
substitution in the premises. 
  

	(2)	Obligations of Assignee. Assignee agrees to take and hold the Warrant and any shares of stock to be issued upon exercise of the rights thereunder (and any shares issuable upon conversion thereof) (the
“Securities”) subject to, and to be bound by, the terms and conditions set forth in the Warrant to the same extent as if Assignee were the original holder thereof. 

 

	(3)	Investment Intent. Assignee represents and warrants that the Securities are being acquired for investment for its own account, not as a nominee or agent, and not with a view to, or for resale in connection with,
the distribution thereof, and that Assignee has no present intention of selling, granting any participation in, or otherwise distributing the shares, nor does it have any contract, undertaking, agreement or arrangement for the same, and all
representations and warranties set forth in Section 11 of the Warrant are true and correct as to Assignee as of the date hereof. 

  

	(4)	Investment Representation Statement and Market Stand-Off Agreement. Assignee has executed, and delivers herewith, an Investment Representation Statement and Market Stand-Off Agreement in a form substantially
similar to the form attached to the Warrant as Exhibit A-1. 

  
 - 1 - 

 Assignor and Assignee are signing this Assignment Form on the date first set forth above. 

 

					
	ASSIGNOR	 		 	ASSIGNEE
			
	 	 		 	 
	(Print name of Assignor)	 		 	(Print name of Assignee)
			
	 	 		 	 
	(Signature of Assignor)	 		 	(Signature of Assignee)
			
	 	 		 	 
	(Print name of signatory, if applicable)	 		 	(Print name of signatory, if applicable)
			
	 	 		 	 
	(Print title of signatory, if applicable)	 		 	(Print title of signatory, if applicable)

  

					
	Address:	 		 	Address:
	 	 		 	 
			
	 	 		 	 

  
 - 2 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}]]